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ABSTRACT
The main goal of the research was the synthesis of new ferrocene peptide
conjugates, to study the role of hydrogen bonding interactions, and the coordination
properties of these systems.

Ferrocene peptide conjugates have been extensively

studied as models of protein secondary structures.

Of particular interest were

disubstituted ferrocene derivatives such as ferrocene dicarboxylic acid, which have been
shown to be important in the design of peptide mimics. The inter-ring spacing between
two cyclopentadienyl rings in ferrocene has shown to be appropriate for forming
hydrogen bonds between conjugated peptide chains, which are attached to the two
cyclopentadienyl rings. Inter-ring spacing has proven to be of great importance for the
formation of stable hydrogen-bonded structures. Additionally, some of these ferrocene
peptide conjugates have the ability to coordinate metal ions. This is of interest because
these systems have the potential to serve as active site mimics of metalloproteins. This
work focused on the synthesis, hydrogen bonding studies, and coordination properties
of novel ferrocene peptide conjugates.

Keywords: ferrocene conjugates, peptides, alanine, histidine, hydrogen bonding, metal
coordination
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CHAPTER 1: Introduction
Bioorganometallic chemistry, which is a hybrid area between biochemistry and
organometallic chemistry, has attracted a lot of attention in recent years. Ferrocene (Fc) is
recognized as a suitable organometallic scaffold for organization of peptide structures.
Ferrocene allows to some extent, control over intramolecular interactions of peptide or
peptidomimetic strands.1-3 The distance between the two cyclopentadienyl (Cp) rings of Fc is
~3.3 Å. When disubstituted Fc derivatives are conjugated to peptides, the inter-ring spacing
allows for formation and stabilization of intramolecular hydrogen bonding interactions of
the attached peptides.4 The resulting ferrocene conjugates often self assemble into highly
ordered structures, which may enhance our understanding of peptide and protein folding
and might lead to the design of new bioactive molecules. The main focus of this thesis is to

explore new ferrocene peptide conjugates, and to evaluate their hydrogen bonding
properties as well as their metal coordination properties.
1.1 Peptides
On a molecular level, all organisms contain common molecules that are responsible
for essential metabolic and structural components of their systems. These include lipids,
carbohydrates, nucleotides and amino acids; the latter of which are the building blocks
of peptides and proteins. α-Amino acids are comprised of an amine group and a
carboxylate group, both bound to a central α-carbon and a side chain, usually denoted
by R (Scheme 1.1.1). The carbon atoms in the side chain are designated as α and β with

1

respect to the carboxylate group (1). Most common amino acids display optical activity;
that is, they have the ability to rotate plane polarized light.5 These optically active
molecules contain stereogenic centers which can interact with light on a macroscopic
level, rotating light. The two stereoisomers of each type of amino acid, L (2) and D (3),
correspond to the same special orientation as the enantiomers of glyceraldehyde that
either rotate polarized light to the left or to the right, respectively.5 The α-carbon can be
either in the S or R configuration, where S and R are assigned according to the CahnIngold-Prelog priority rules. Often, the S stereocenter gives rise to an L-amino acid. The
R configuration gives rise to the D-amino acid, with the exception of L-Cys, as the heavy
sulfur atom has increased priority and, therefore, has the opposite configuration.6
Additionally, the side chain alters the physical properties of the amino acid, such as its
solubility, and influences the spatial orientation of a growing peptide chain. The side
chain may also act as a ligand towards a metal ion.

Scheme 1.1.1. The amino acid His (1) is shown as the L-configuration, where side chain
carbons are designated as α, β. The imidazole ring positions are designated as 1, 2, 3, 4,
and 5. The general structure of all common α-amino acids of (2) L-isomer and (3) Disomer are shown, with side chains denoted by R.7

2

A dipeptide is formed by the condensation reaction of two amino acids with
elimination of water, as shown in Scheme 1.1.2. As amino acids are coupled together,
either by enzymatic reactions in vivo or in vitro, or by synthetic coupling reactions,
peptide bonds are formed between the amine of one amino acid and the carboxyl group
of the second amino acid (Scheme 1.1.2). In a typical synthetic peptide coupling
reaction, it is necessary to first activate the relatively non-electrophilic carboxylate
group of one amino acid to facilitate nucleophilic attack of the second amino acids
amino group, yielding the desired peptide. The resulting dipeptide has an N-terminus
(Nterm) and a C-terminus (Cterm) (6).

Scheme 1.1.2. General reaction scheme for peptide bond formation: the condensation
reaction of two amino acids 4 and 5 to form dipeptide 6 and a water molecule. 6 shows
the N- and C-terminal sides highlighted in the box and designated Nterm and Cterm
respectively. The peptide bond is shown in bold, and the amino acids and the dipeptide
are shown as the zwitterionic forms, as they exist at physiological pH. It should be noted
that chirality of the resulting dipeptide is retained.8

In chemical stepwise solution phase synthesis, suppression of reactive functional
groups in the selected amino acids is required to prevent unwanted side products from
forming. This is usually achieved by introduction of protective groups. Ideally, these
groups can be selectively removed or maintained throughout this process if desired. The

3

first modern protecting group introduced in peptide synthesis for Nterm protection was
the carboxybenzyl (Cbz or Z) introduced by Bergmann and Zervas.9

More recent

examples of Nterm protecting groups are the tert-butyloxycarbonyl (Boc) group and the
fluorenylmethyloxycarbonyl (Fmoc) group, while the Cterm is often protected as a methyl,
ethyl or benzyl ester (Scheme 1.1.3).10,11 The Boc protecting group is acid sensitive and
can be removed by trifluoroacetic acid (TFA).11,12 Methyl and ethyl esters can be
removed by base hydrolysis, while benzyl ester requires hydrogenolysis using hydrogen
gas and usually uses a palladium catalyst.11 Fmoc is base labile and typically removed in
a solution of piperidine 20 % in (dimethylformamide) DMF cleaved by other simple
nitrogen bases.11-12 Because the scope of the research was limited to select amino acids,
the only side chain protecting group used was the 2,4-dinitrophenyl (DNP) for the
imidazole of histidine (8).

Others side chain protecting groups will not be discussed.

Common protecting groups and reagents used in peptide synthesis have been recently
reviewed.10-12 2,4-Dinitrophenyl is a useful protecting group because it reportedly
reduces racemization in peptide synthesis because of its electron-withdrawing
character.

It also has the desirable feature of being resistant to acidic and basic

conditions, and thus can function as a orthogonal protecting group.13 Orthogonal
protection is a strategy allowing for selective deprotection of functional groups
independently of each other. Removal of DNP is achieved by thiolysis cleavage, using a
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thiol such as thiophenol or 2-mercaptoethanol liberating the nitrogen at position 1 of
the imidazole and a DNP-thiol.14-17

Scheme 1.1.3 Protective groups of various alanine and histidine derivatives. Fmoc-AlaBn (7), The fluorenylmethyloxycarbonyl (Fmoc) protective group can be introduced to an
amide R-NH2 by way of fluorenylmethyloxycarbonyl chloride (Fmoc-Cl) or through 9fluorenylmethyl succinimidyl carbonate (Fmoc-OSu), the Fmoc group is base labile and
usually removed using a simple nitrogen base such as piperidine or 1,8Diazabicyclo[5.4.0]undec-7-ene (DBU). The imidazole in histidine can be reacted with
2,4-dinitrofluorobenzene and potassium carbonate to yield the 2,4-dinitrophenyl (DNP)
containing peptide, H-His(DNP)-OH (8) is an example of a DNP protected histidine.
Carboxybenzyl (Cbz) can be used to protect amines, it can be introduced using benzyl
chloroformate and a weak base, for example Cbz-Ala-OMe (9). The protective group
tert-butyloxycarbonyl (Boc), seen in the compound Boc-Ala-OEt (10) can be introduced
by using the anhydride di-tert-butyl dicarbonate and is acid labile, commonly removed
with trifluoroacetic acid (TFA).10-11

The next step is peptide bond formation, where typically the carboxylic acid
moiety of one amino acid is activated by an appropriate coupling reagent, and then
reacted with the amino component of a second amino acid yielding the desired
dipeptide. Scheme 1.1.4 shows the activation of the carboxylate group which can be
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generated in multiple ways to form the acyl chloride (12) or various active esters; the
benzotriazolyl active ester (13) or the succinimide based active ester (14). The active
ester derivatives are synthetically accessible using carbodiimide, uronium, and
phosphonium type reagents. The active ester intermediates play a dual role as reaction
rate enhancer and racemization suppressors.10,12,14

Scheme 1.1.4 Common synthetic pathways for amide bond formation. Reagents and
conditions: Acyl chlorides 12 are commonly prepared by the reaction of the carboxylate
moiety with (i) oxalyl chloride ((COCl)2), or thionyl chloride (SOCl2). (ii) The benzotriazolyl
active 13 ester is prepared using 1- hydroxybenzotriazole (HOBt) with a carbodiimide
reagent such as EDC 1-ethyl-3-(3-dimethyllaminopropyl)carbodiimide or N,N'dicyclohexylcarbodiimide (DCC), or a uronium reagent such as O-(benzotriazol-1-yl)N,N,N’,N’-tetramethyluronium hexafluorophosphate (HBTU) or a phosphonium reagent
such as benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium hexafluorophosphate
(BOP) reagent. (iii) The succinimidyl active ester 14 is prepared by reaction with Nhydroxysuccinamide (HOSu) using a carbodiimide coupling reagent such as EDC or DCC
in CH2Cl2. The intermediates can be prepared in situ or can be isolated as stable
derivatives, upon further reaction with an amide yields 15. 10,12,18

Koenig and Geiger19-20 introduced HOBt (16) as an additive that forms the active
ester to reduce racemization when using carbodiimides. When HOBt was used as an
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additive, yields were higher and racemization was lower. For instance, when coupling ZGly-Phe-OH to H-Val-OMe, the racemization levels dropped from 35% to 1.5%. Scheme
1.1.5 shows the reaction pathway of HOBt to form the stable isolatable active ester
(Scheme1.1.5 F). HOBt is believed to work by an initial reaction with the O-acylurea
(Scheme 1.1.5 C) to give the OBt active ester (Scheme 1.1.5 F), which enhances the
reactivity of the activated ester.15 The succinimide activated ester (14) is also sometimes
used in suppressing racemization.

Benoiton and co-workers.18,21 did a series of

experiments comparing N-hydroxysuccinamide (NHS) and HOBt reagents and concluded
that HOBt is about twice as effective at suppressing racemization as NHS.

Scheme 1.1.5 The activation of a carboxylate (A) using a carbodiimide reagent (B). The
reactive intermediate in peptide coupling, the O-acylurea (C) can further reaction in the
presence of 1-hydroxybenzotriazole (HOBt, 16) to yield the benzotriazole active ester
(F). The O-acylurea may undergo a rearrangement to an N-acylurea (E) which is inactive
and may be hard to separate. Experimental evidence shows that the OBt active ester
suppresses racemization and increases reaction rates. Reaction of (F) or (C) with an
amino component gives the corresponding amide (D). 10,12,18,22
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Racemization occurs due to many reasons; one of them being that the Cterm
during activation of an amino acid residue may form a cyclic oxazolone (18, 20)
intermediate, which can undergo enolization (19). The oxazolone can then couple to an
amine, forming the racemized product (Scheme 1.1.6).10,18,23-25

Scheme 1.1.6 Oxazolone formation: a racemization pathway exists where an acyl
peptide (17) may undergo nucleophilic attack by an adjacent carbonyl into the
oxazolone (18). Oxazolone formation is caused by the activator Y, which causes the
carbonyl beside it to become electrophillic, and may undergo an attack by the adjacent
carbonyl to form the oxazolone (18). The oxazolone can then enolize to where it loses
stereogenicity at the α-carbon (19) and can undergo tautomerization to form (20). Rate
of isomerization depends dramatically on the nature of the base as well as the polarity
of the sovent, being as much as 50 to 100 times greater in dimethylformamide than in
CH2Cl2. Although (17) may undergo structural changes to form the oxazolones (18) and
(20), the oxazolones can undergo nucleophilic attack at the transformed carbonyl group
by an amide functional group resulting in (21). 10,18,23-25
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Further racemization can occur after formation of the peptide bond, most
frequently through a base mediated enolate pathway (Scheme 1.1.7).

The base

mediated pathway involves the direct removal of the α-proton by a base, where the
resulting electron pair migrates to generate an equilibrium between A, B and C (Scheme
1.1.7). The equilibrium can enolize between the carbanion and the oxoanion, when the
double bond is shifted to the α-carbon, resulting in a loss of stereogenicity.
Racemization occurs during the base-catalyzed coupling reaction of N-protected,
carboxyl-activated amino acids, and it takes place in the intermediate oxazolone that
forms readily from an N-acyl protected amino acid.18,23-25

Scheme 1.1.7 Base catalyzed epimerization: enolization of an amino acid sequence can
occur by the introduction of a base due to reaction conditions or can be caused by
functional basic groups of amino acids, such as the imidazole ring in histidine or lysine.
The process results in racemization at the stereogenic α-carbon. Introduction of a base
to the keto form (A) can result in the formation of the enolate (B), which has a loss
stereogenicity. Reprotonation generates two configurations of the residue (A), and
(C).18,23-25
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1.2 Hydrogen bonding in peptides
As amino acids are coupled, they form a linear peptide strand. This strand can then
be arranged into various secondary structures stabilized by inter- and intra- molecular
hydrogen bonding interactions and the steric demand of the amino acid side chains.
Many factors contribute to the stability of the secondary structure, including the nature
of the amino acid side chains, metal coordination, pH, temperature, and solvent
polarity.8 Common secondary structural elements found in proteins include β-sheets, αhelices, and various turns. Scheme 1.2.1 shows some of these structural elements.

Scheme 1.2.1 Schematic representations of select secondary structures: A parallel βsheet showing the hydrogen bonding (dashed lines) between the NH and C=O backbone
residues of adjacent strands (A), arising from 12 membered hydrogen bonded rings.
Antiparallel β-sheets (B) arise from alternating 10 and 14 membered hydrogen bonded
rings, caused by strands running in opposite directionality, Cterm to Nterm, where parallel
β-sheets run Cterm to Cterm or vice versa. The β-sheet strands are separated by ~ 3.5 Å
from adjacent strands. A β-turn is depicted in C, where the turns are characterized by
the amino acid residues i and i+3 engaging in hydrogen bonding, forming a 10membered ring system shown by the dashed line starting from the C=O of residue I and
the Nterm amide hydrogen of residue i+3.
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1.3 Metal coordination in peptides
There are a wide variety of metalloproteins that utilize a small number of amino
acids possessing suitable side chains that often allow for effective metal binding.
Because of the large size of metalloproteins, small molecules are often used as model
systems to determine which structural and functional characteristics are essential to the
role of metal ions in metalloproteins. Short chain peptides can be used to mimic some
of the coordination sites in metalloproteins. Numerous synthetic studies of metal
complexes of peptides have been carried out and it is clear that coordination modes are
strongly influenced by the amino acid sequence of the ligands. Histidine (His), cysteine
(Cys), aspartic acid (Asp), glutamic acid (Glu), tyrosine (Tyr) and methionine (Met) are
commonly involved in metal coordination in proteins. Histidine coordinates through its
imidazole group in its side chain, while Cys will involve its thiol to form metal thiolates.
Aspartic acid and glutamic acid engage in coordination through their side chain
carboxylate. Methionine can coordinate through its sulfur atom and tyrosine through its
phenolic oxygen. Peptides can also coordinate through their backbone atoms,
specifically the nitrogen in the amine, and the carboxylate groups.
There are several examples of de novo designed peptide based systems, where
binding of metal ions changes the conformation of the system, often resulting in
formation of secondary structures in these systems. Simple peptide sequences such as
Ala-HisNHOH have shown pH dependent coordination modes, for example, in the
11

presence of Cu2+, the sequence can adopt a tridentate coordination via the amino-N,
carbonyl-O and imidazole-N to the peptide and further coordinate to a solvent molecule
(22).26

Figure 1.3.1 Metal ion complexes of short chain peptides. Compound 22 is the metal
complex between Ala-HisNHOH and Cu2+. Compound 23 is the metal between Ala-AlaHis and Ni2+. Compound 24 is the metal complex between Ni2+ and two Gly-Gly
dipeptides.

Additionally, in the presence of an equimolar solution of the tripeptide Ala-AlaHis, to Ni2+, the resulting complex adopts a square planar coordination geometry around
the metal center with pH control, in the presence of the 4 coordinate ligand (23).27In
contrast, two equivalents of the dipeptide Gly-Gly in a basic solution, form the
hexacoordinate Ni2+ complex coordinating through 2 nitrogens of each glycine and the
carboxylate of the Cterm(24). At higher pHs, there is a transition from a hexacoordinate
paramagnetic complex to a diamagnetic square planar complex.

The change to

diamagnetism becomes evident by the change observed in the NMR spectra of the
compounds. 28-31
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Schneider and Kelly32 discovered a system bearing a bipyridine-based molecular
scaffold, that incorporates peptides to promote β-sheet folding upon addition of Cu2+,
from a random coil structure of the attached peptides (Scheme 1.3.1). The coordination
of Cu2+ results in a square planar complex, which brings the attached peptide strands
into appropriate dimensions for β-sheet folding.

Scheme 1.3.1 Transition from random coil conformation illustrated in 25, mediated by
Cu2+ binding within peptides and the bipyridine based scaffold, promoting hydrogen
bonds between the two peptide strands. The resulting complex 26 resembles
antiparallel β-sheets.31
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1.4 Ferrocene peptide conjugates
Ferrocene (Fc) is the first known and prototypical metallocene discovered by
Kealy and Pauson.33 In 1952, Wilkinson et al.34 deduced the structure of Fc based on its
reactivity, and independently, Ernst Otto Fisher35 also came to the same conclusion
about the structure of Fc. Ferrocene is composed of two cyclopentadienyl (Cp) rings on
opposite sides of a central Fe2+ center. Ferrocene adopts an eclipsed conformation in
the gas phase but solids exist in several conformations in which the rings are co-parallel
but in different orientations, due to a low rotation barrier. In the X-ray crystal structure,
Fc adopts the staggered conformation (Figure 1.4.1).

Derivatives of Fc with large

substituents on the two Cp rings cause them to be staggered.36 Monosubstituted Fcpeptide conjugates were first reported by Schlögl37 as early as 1957, where he also
reported the first two Fc amino acid analogues D/L-ferrocenylalanine (28) and D/Lferrocenylphenylalanine (29).

Figure 1.4.1 Illustrating Fc in the eclipsed and staggered conformations (27).
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Figure 1.4.2 Chemical structures
ferrocenylphenylalanine (29). 37,38

of

D/L-ferrocenylalanine

(28)

and

D/L-

The Fc scaffolds ferrocenylcarboxylic acid (30) and ferrocenyl amine (31) have
been used to obtain Fc-peptide conjugates. Monosubstituted Fc-peptide conjugates
provide little control over the self assembly of peptides and generally aggregation
cannot be directed and is left up to chance.

Scheme 1.4.1 Structure of two ferrocene derivatives ferrocenylcarboxylic acid (Fc-CO2H,
30) and ferrocenyl amine (Fc-NH2, 31). These derivatives can be coupled to peptide
sequences using typical coupling reagents and conditions to yield different directionally
peptide conjugates. Fc-carboxylic acid conjugate A shows the Nterm side of the peptide
attached to the Fc while Fc-amine conjugate B has the Cterm of the peptide attached to
the Fc.
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Previous studies have shown that disubstituted 1,n’-Fc derivatives are useful as
organometallic

scaffolds,

with

various

uses

in

catalysis,

notably

1,1’-

bis(diphenylphosphino)ferrocene (dppf). As well, they can be used in biosensors, and in
the preparation of various functional materials. 39,40
The inter-ring separation in Fc is about 3.3 Å which is an appropriate distance for
stabilizing hydrogen bonding between peptide strands in disubstituted Fc systems.
Ferrocene has a low rotational barrier about the Cp-Fe-Cp axis, which enables the Cp
rings to rotate, and allows the substituents on the rings to adopt unstrained stable
alignments. Because of the low rotational barrier, and the inter-ring separation, Fc has
been shown to be a suitable molecular scaffold for the design of secondary structure
mimics of peptides with well defined structures.8
The initial work of exploring Fc-conjugates of peptides and amino acids was
reported by Herrick et al.41 Hydrogen bonding interactions have been extensively
studied, providing detailed information about molecular structure of the crystalline solid
Fc-conjugates, including intra- and inter- molecular hydrogen bonding. The structure of
the Fc-conjugates in solution has been determined by NMR, IR, and CD spectroscopic
techniques.
In 1996, Herrick et al.41 reported the synthesis of disubstituted-Fc amino acid
conjugates, where substituents engage in two equivalent intramolecular hydrogen
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bonds between the amide NH group of one Cp strand and the carbonyl CO group of the
peptide substituent on the opposite Cp strand, as shown in Scheme 1.4.2. The hydrogen
bonding interactions create a 10-membered ring that is similar to that in a β-turn and
render the molecule rigid in one locked conformation.

Scheme 1.4.2 Intramolecular hydrogen bonding of Fc[CO-L-Phe-OMe]2 (32). Hydrogen
bonds are shown as dashed lines, system is engaging in 10 membered hydrogen bonding
ring.41

Different hydrogen boding patterns are possible in peptide conjugates of
disubstituted Fc. For example, most disubstituted Fc-peptide conjugates of 1,n’-Fc
dicarboxylic -type display two hydrogen bonding interactions that lock the central Fe2+
core into a specific helical conformation, known as the “Herrick” conformation (36).
Depending on the attaching functional groups that connect to the Fc (COOH or NH2), and
the sequence of amino acids selected, the hydrogen bonding pattern interactions can be
controlled to some degree (Scheme 1.4.3).
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Scheme 1.4.3 Structures of 1,n’-disubstituted ferrocene scaffolds. Fc-dicarboxylic acid
(33), Fc-diamine (34) and Fc-amino acid (Fca, 35). Conjugation to the Fc scaffolds allows
formation of parallel (A, B) and anti-parallel (C) alignment of the peptide substituents.
Different scaffold units control the hydrogen bonding interactions, allowing for different
hydrogen bonded rings. A adopts a 10 membered ring; B adopts a 14 membered ring;
and C adopts a 12 membered ring.

Other hydrogen bonding arrangements exist, for example, if they possess a single
hydrogen bond between the peptide strands such as the “semi-Herrick” (37) or the “van
Staveren” (38) conformations. It is also possible that there are no hydrogen bonding
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interactions between the peptide strands such as in the “Xu” conformation (39). The
resulting hydrogen bonding interactions of the bonding patterns which contain
intramolecular hydrogen bonding, provide a significant degree of rigidity. Because of
this, the disubstituted Fc-peptide conjugates adopt one stereoisomer form in which the
Fc group displays axial chirality.42-47
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Scheme 1.4.4 Hydrogen bonding arrangements of 1,n’-disubstituted Fc peptide
derivatives. When two intramolecular hydrogen bonding interactions occur at the Fc
core, the result is in the “Herrick” conformation (36). When one intramolecular
hydrogen bonding interaction occurs, it may adopt one of two conformations, the “semiHerrick” (37) or the “van Stavern” (38). Alternatively, when the peptides engage in no
intramolecular hydrogen bonding, they result in the “Xu” conformation (39).36-41
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Experimentally, it was determined that the amino acids having stereogenicity of
the α-carbon produce axial chiral organizations with respect to the Fc core.48 The axial
chirality at the Fc core is denoted by systematic nomenclature in order to indicate
relative orientation of the substituents on the two Cp rings with respect to each other.42
The torsion angle between the two substituents on the 1,n’-disubstituted ferrocene core
is designated ω, that is used to define any positional isomer (Scheme 1.4.5). Priority of
the top and bottom substituents on the Fc are assigned according to the Kahn-IngoldPrelog rules.6,42
Fe
P

3

4

2 Fe 5
1
ω

M
180°
1,3' 1,4'
108°
-108°
Fe
1,5'
1,2'

1,1'

A

P-1,3'

M-1,4'
enantiomers

-36°

36 °

Fe

Fe

Fe

P-1,2'

B

M-1,5'
enantiomers

C
Scheme 1.4.5 Ferrocene axial chirality: The dihedral angle ω denotes the torsion angle
on the 1,n’-disbustituted Fc-conjugate (A). Rotation of the two Cp rings results in
different isomers for 1,n’-disubstituted ferrocene derivatives (B). Possible arrangements
for substituents on the two Cp rings are depicted in (C).42

The top priority substituent is always oriented in position 1, and the lower
priority substituent is placed in n’ position, where P and M are the axial designations.
The P-isomer is observed as a result of a clockwise rotation about the Fc core, and the
M-isomer is observed as a result of a counter clockwise rotation about the Fc core.
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Additional positional indicators can be denoted when substituents are in the 2’,3’,4’and
5’ positions according to Scheme 1.4.5. For example, a P-1,2’ isomer is defined as 36°<
ω < 108° and an M-1,5’ isomer is between -108° and -36°. A 1,1’-isomer is defined as
when the peptide conjugate has a torsional angle between 36° and -36°.

Chiral amino acids and peptides largely control which helical isomers are formed.
The L-amino acids give rise to a P-helical conformation (with the exception of L-Cys),
while the D-amino acids give rise to the M-helical conformation (with exception of DCys) of the Fc-conjugates.49 This has consequences that can be observed by circular
dichroism (CD) spectroscopy. CD is observed when optically active matter absorbs left
and right handed circularly polarized light slightly differently. The difference in left and
right handed absorbance is very small. CD has a wide variety of applications in many
different fields, most commonly to investigate and interpret biological macromolecules,
such as protein sequences, protein secondary structures, and CD can be used to assess
the assembly processes leading to the formation of helical superstructures.50
Additionally, CD has been used to investigate helical conformations of Fc-peptide
conjugates. Previous investigations on Fc-peptide conjugates have shown that P-helical
structures exhibit a positive Cotton effect in the Fc region at ~ 440-480 nm, and Mhelical systems display a negative Cotton effect in this region.51,52 The CD pattern for
Fc[CO-L-Ala-OMe]2 (40) and Fc[CO-D-Ala-OMe]2 (41) in the region 300-600 nm is shown
21

in Figure 1.4.2.53 From the CD spectra, it is clear that conjugates 40 and 41 are the exact
opposite of each other, indicating a chiral rigid structure which is maintained in both the
solution phase and the solid phase. These peptide conjugates result in a 10 membered
hydrogen bonded ring. Many other Fc-peptide conjugates have been studied and
display similar CD patterns.45,46

Figure 1.4.3 CD spectra of Fc[CO-L-Ala-OMe]2 (40) represented by the full line and
Fc[CO-D-Ala-OMe]2 (41) represented by the dashed line. The two enantiomers display
CD spectra that are mirror images of each other. Materials reprinted with permission
from Ref. 53, by permission from the Royal Society of Chemistry.

Rapić et al.54 prepared a ferrocene amino acid derivative of Boc-Val-Fca-Val-OMe
(42), which has a strong λmax at 468 nm, in CH2Cl2, which is reduced in intensity by 5060% when DMSO is added as a competitive hydrogen accepting solvent. The helical
conformation of the Fc unit, which is enforced by two intramolecular hydrogen bonds, is
strongly favored in CH2Cl2, and is partially disturbed by DMSO (Figure 1.4.4). It should be
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noted, if the Fc peptide conjugate is strongly hydrogen bonded, it will retain its rigid
structure in the presence of DMSO and no decrease in CD intensity is observed.54

Figure 1.4.4 CD spectra of Boc-Val-Fca-Val-OMe (42) in CH2Cl2 (solid line) and
CH2Cl2/DMSO (dashed line) (20% v/v). Introduction of DMSO causes a decrease in
intensity when DMSO is added. Spectra reproduced with permission Ref 54. Copyright
2009 American Chemistry Society.
The hydrogen bonding interactions in Fc-peptide conjugates have been
extensively studied by 1H-NMR spectroscopy. In general, in non-coordinating solvents
such as CDCl3 and CD2Cl2, the amide protons involved in hydrogen bonding interactions
exhibit a chemical shift above 7 ppm.37 Variable temperature (VT) NMR and variable
concentration (VC) NMR spectroscopic studies are used to evaluate and compare the
strength of hydrogen bonding interactions. An increase in temperature causes hydrogen
bonding interactions to weaken; this is readily detected by NMR spectroscopy. If
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hydrogen bonding interactions are present, an increase in temperature will weaken
these interactions, resulting in an upfield shift of the resonances assigned to the amide
protons. Studying the concentration dependence on chemical shift will allow evaluation
of which amide protons are involved in intermolecular hydrogen bonding interactions.
Drexler et al.55 studied VT 1H NMR of compound 43 and found a temperature dependent
shift of △δ/△T= -7.36 ppb K-1, -6.64 ppb K-1, -4.01 ppb K-1 for amides NHa, NHb and
NHc, respectively (see Figure 1.4.4 for assignment of amides). Amides NHa and NHb are
engaging in strong hydrogen bonding interactions which can be observed by their high
temperature dependence, while amide NHc is only weakly hydrogen bonded compared
to the other two.
O
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Figure 1.4.5 VT 1H-NMR of compound 43 in CDCl3 from 300K-318K, shifting to higher
field indicating the weakening of hydrogen bonding interaction, as temperature
increases. Compound 43 showing intramolecular hydrogen bonding by dashed lines.
Materials reprinted with permission from Ref. 55, by permission from the Royal Society
of Chemistry.
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VC 1H NMR spectroscopy is used to evaluate intermolecular hydrogen bonding. At
low concentrations, in conjunction with VT, 1H-NMR can be used to distinguish between
intramolecular and intermolecular hydrogen bonding interactions. For example, Cheng
et al. 56 reported a Fc-peptide conjugate Fc[CO-His(DNP)-Gly-OMe]2 (44), with chemical
shifts of amide protons Ha and Hb △δ/△T= -6 ppb/K for NHa and -3.2 ppb/K for NHb.
Only NHb showed dramatic concentration dependant shifts, at higher concentrations,
which indicates that NHb of His is engaged in intramolecular interactions, and NHa of Gly
is engaged in intermolecular hydrogen bonding (Figure 1.4.6).

a)

b)
Figure 1.4.6 Plots showing the effects of temperature and concentration on the chemical
shift of the amide protons of compound 44. (a) VT 1H NMR plot showing the
temperature dependant behavior of compound 44s amide protons NHa and NHb, at
293.15, 298.15, 303.15, 308.15, 313.15, and 318.15 K ([44]= 1 mm, CD3CN). (b) VC 1H
NMR of compound 44, showing the change in the amide protons NHa and NHb, at
concentrations 1,2,5,10,20 mM in CD3CN. Materials reproduced with from Ref. 56, with
permission from John Wiley and Sons.
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Another method of determining which amide protons are engaged in interstrand
hydrogen bonding is comparing the chemical shifts of

1

H-NMR spectrum of a

monosubstitued Fc reference compound to a disubstituted Fc conjugate’s 1H-NMR
spectrum in DMSO. DMSO is a known hydrogen bond acceptor, and competes with the
C=O hydrogen bond acceptor sites within the Fc-peptide conjugates.39,41,57 Usually, a
reference compound of monosubstituted Fc conjugate is used and its chemical shifts in
CDCl3 and DMSO-d6 are compared to the chemical shifts of the disubstituted Fc
conjugate of interest to determine which amide protons are engaging in inter-strand
hydrogen bonding. A small chemical shift of the amide protons from CDCl3 to DMSO-d6
(△δNH) with a value near zero indicates the system is in a hydrogen bonded state; a
large shift >1 ppm indicates non-hydrogen bonded state.

Strong intramolecular

hydrogen bonds cannot be disrupted by DMSO-d6. Kovač et al.57 described a new
method to elucidate inter-strand hydrogen bonding in Fc-peptide conjugates, known as
the “chemical shift of variations”. In this method, hydrogen bonding of amide protons is
evaluated in comparison between the chemical shift of the amide protons in CDCl3 and
DMSO-d6, but without the need for reference compounds. Kovač et al.57 defined a range
of △δNH to estimate specific hydrogen bonding. The small shift of variation △δNH <0.6
ppm suggests strong hydrogen bonding, and △δNH > 1 indicates a non hydrogen bonded
proton, while △δNH - 0.6-0.9 ppm indicates a medium strong hydrogen bond. Recently,
Lataifeh and Kraatz58 prepared a series of Fc-Asp dendrimers and evaluated hydrogen
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bonding patterns by comparing the chemical shifts of the amide protons (△δNH) to the
reference compound Fc[CO-Asp(OMe)-OMe] (45) to its disubstituted counterpart Fc[COAsp(OMe)-OMe]2 (46).58 In compound 45, the amide proton of Asp had a large chemical
shift difference in DMSO-d6 of 1.45 ppm relative to CDCl3. This indicates that the amide
proton is free and non hydrogen bonded. Analysis of 46 revealed only a moderate shift
of 0.72 ppm, which is characteristic of a symmetrical conjugate with medium strong
inter-strand hydrogen bonding between the NH amides and C=O of the ester.

Figure

1.4.7 shows the hydrogen bonding pattern.

Figure 1.4.7 Chemical drawings of Fc-CO-Asp(OMe)-OMe (45) and Fc[CO-Asp(OMe)OMe]2 (46). Compound 46 is engaging in the Herrick hydrogen bonding pattern,
hydrogen bonding interactions illustrated by dashed lines.

In infrared (IR) spectroscopy, the amide protons of Fc-peptide conjugates display
a characteristic signal in the amide A region, in which a signal below 3400 cm-1 suggests
the presence of hydrogen bonded amides. If the IR absorption is observed to be higher
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than 3400 cm-1, it indicates the presence of free amides.41,53 Additionally, the vibrational
stretching that originates from the C=O in the range of ~1600-1700 cm-1, known as
amide-I region, can be used to distinguish hydrogen bonding interactions, causing a shift
to lower frequencies.59 The amide II region (1510-1580 cm-1) can also provide details
about hydrogen bonding of peptides but to a lesser degree.

1.5 Metal coordination in ferrocene peptide conjugates
Limited coordination chemistry has been carried out of Fc-peptide conjugates
with metal ions. Metal ions interact with Lewis basic nitrogen and oxygen sites of the
peptide backbone. Functional groups such as the imidazole of His, the thiol of Cys, and
pyridine have been introduced into peptide sequences of Fc-peptide conjugates to
promote metal coordination. 46,60-63
In 2008, Scully et al.60 reported a Fc-cysteine derivative (47) which showed
remarkable redox activity when binding with Hg2+ over other metals, and only weakly
interacts with Cd2+, Zn2+, Ag2+, and Pb2+. From the X-ray crystal structure, it adopts the
“Xu” conformation, with substituents oriented opposite each other with no
intramolecular hydrogen bonding. NMR bonding studies show a downfield shift upon
addition of Hg(NO3)2 of the S-CH3 protons from 2.12 ppm, moving to 2.28 ppm with 0.5
equiv. and 2.44 ppm with 1 equiv. Job plots reveal a 1:1 binding stoichiometry.
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Figure 1.5.1 Molecular drawing and crystal structure of Fc[CO-Cys(Me)-OMe]2 (47),
Showing Fc core adopting the “Xu” conformation, with no intramolecular hydrogen
bonding. Thermal ellipsodies are drawn at 50% probability level. Materials reproduced
from Ref. 60 with permission from Elsevier.

Figure 1.5.2 Partial 1H-NMR titration spectrum of compound 47, the methyl protons of
S-CH3 shifting from 2.12 ppm, moving to 2.28 with 0.5 equivalents and 2.44 with 1
equivalent of Hg(NO3)2. Materials reproduced from Ref. 60 with permission from
Elsevier.
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Another cysteine containing Fc peptide derivative was reported by by Hatten et
al.63 in 2008. In the Fc-peptide, the two sulfur atoms of Cys coordinate to a Fe2(CO)6
fragment, which leads to the formation of the complex Fc[CO-Cys-OMe]2[Fe2(CO)6] (48)
which is the first Fc peptide model for the active site of iron hydrogenase.

Figure 1.5.3 Molecular drawing and crystal structure of Fc[CO-Cys-OMe]2[Fe2(CO)6] (48),
showing sulfurs coordinate to a Fe-carbonyl fragment. Materials reproduced from Ref.
63 with permission from John Wiley and Sons.63

As previously mentioned, Cheng et al.56 reported a His containing Fc-peptide
conjugate 44. The Fc conjugate can coordinate to a wide variety of metal ions through
the imidazole of His which forms metal complexes which can be detected by mass
spectrometry (MS), as shown in Figure 1.5.4. According to the CD spectra study, the
system exhibits a CD band in the Fc region with a positive Cotton effect at λ = 480 nm,
indicating a P-helical conformation around the Fc group. After addition of Mg2+, the CD
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signal remains positive, maintaining its P-helical structure (Figure 1.5.5 a). In contrast,
the addition of Cu2+ ions appears to cause significant conformation changes to a Mhelical arrangement as seen in Figure 1.5.5 b.
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a)

b)

OMe

Figure 1.5.4 Partial ESI-TOF-MS results showing the experimental and theoretical
isotopic pattern of the Cd2+ complex of Fc[CO-His(DNP)-Gly-OMe]2. Molecular ion peak
of 49 assigned to [M + Cd – H]+. Left: calculated molecular isotopic distribution for [M +
Cd – H]+; right: observed partial spectrum. MS reproduced from Ref. 56, with permission
from John Wiley and Sons.
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a)

b)

Figure 1.5.5 CD spectra of Mg2+ and Cu2+ metal complexes with 2 equiv. of metal ions
with compound 44 (dash line) compared with compound 44 (1 mM, solid line) in
acetonitrile. Indicating that the axial chirality of Fc is maintained upon coordination of
Mg2+and is changed when coordinated to Cu2+. Materials reproduced from Ref. 56, with
permission from John Wiley and Sons.

Moriuchi and coworkers61,62 reported a Fc-peptide conjugate, Fc[CO-Ala-ProNHPy]2 (53), which incorporates the podent peptide chain -Ala-Pro-Py. The NH of Ala
engages in intramolecular hydrogen bonding between the adjacent C=O of Ala. The Pro
induces a turn in the sequence and the pyridine also allows for metal coordination
through the nitrogen atom’s basic lone pair of electrons. Coordination of Pd2+ to the
two pyridine groups yielded the Pd complex (54). The coordination complex showed a
downfield shift of 0.2 ppm in the 1H NMR spectrum compared with (53), indicating
stronger intramolecular hydrogen bonding interactions. In the CD spectrum, some
changes in lower wavelengths (200-350 nm) result from changes in the podent peptides.
The P-helicity of the Fc-core is maintained as shown in Figure 1.5.6. 61,62
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Figure 1.5.6. CD spectrum of Fc[CO-Ala-Pro-Py]2 (50) represented by the dashed line,
and solid in the presence of Pd2+ in CH2Cl2. The retention of the peak at 480 nm
indicates retention of the P-helical conformation upon coordination of the pyridine
groups to Pd2+. Spectra reprinted with permission from Ref. 62 Copyright 2001 American
Chemical Society.

In the solid state, when comparing the structure of 50 with the metal free Fcconjugate and 51, the metal coordination causes a stronger alignment of the peptide
chains, as a consequence, the intramolecular hydrogen bonding lengths are reduced
from d(N1···O2*) = 3.01(1) Å before metal complexation to 2.88(1) Å after complexation.
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Figure 1.5.7 Crystal structure of Fc[CO-L-Ala-L-Pro-NHPy]2 (50) its Pd2+ complex (51).
Note the square planar coordination environment of the Pd center and trans
arrangement of the pyridine groups. ORTEP representations reprinted with permission
from Ref. 62, Copyright 2001 American Chemical Society.

1.6. Objectives
The objective of research described in this thesis is to explore the preparation
and structures of ferrocene peptide conjugates and their coordination behavior with
metal ions, since little work has been done in this area. Herein, we plan to discuss a
synthetic study in which we synthesize a number of His containing peptide conjugates
and their hydrogen bonding interactions. These ferrocene peptide conjugates with Lamino acids are expected to exhibit a P-helical conformation. Histidine was chosen since
it is well-known to coordinate with metals. Additionally, ethylene diamine was used for
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its flexibility and coordination properties. Construction of hydrogen bonding between a
carbonyl group and amide proton in these new conjugates should help us to understand
and rationalize the structures of potential coordination sites of ferrocene-peptide
conjugates. In addition, this system can help us to understand chiral organization
patterns of ferrocene conjugates. Furthermore, ferrocene peptide conjugates will be
studied in the presence of metal ions in these conjugates, which are expected to
produce potential stable structures. The effects on the axial chirality of the ferrocene
group will be evaluated.
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CHAPTER 2: Experimental
2.1 General methods
All

reactions

were

carried

out

in

air

unless

otherwise

indicated.

Dichloromethane (CH2Cl2) was distilled in CaH2 and stored over 4 Å molecular
sieves (Fisher) before use. Methanol (MeOH) was distilled using anhydrous
magnesium turnings prior to use. Deuterated chloroform (CDCl3) was stored
over 4Å molecular sieves before use and obtained from Cambridge Isotopes
Laboratories Inc. Dimethyl sulfoxide-d6 (DMSO-d6) and acetontitrile-d3 (ACN-d3)
were obtained from Sigma-Aldrich, and ACN-d3 was stored under 3 Å molecular
sieves (Fisher) before use. LiOH, NaOH, NaHCO3, NaCl, citric acid (C6H8O7),
tetrahydrofuran (THF), diethyl ether (Et2O), chloroform (CHCl3), dichloromethane
(CH2Cl2), hexane, MeOH, ethyl acetate, and acetonitrile were received from VWR
International, LLC. Coupling reagents, including 1-hydroxybenzotriazole (HOBt),
O-benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate
N,N’-dicylcohexylcarbodiimide

(DCC),

(HBTU),

N-(3-dimethylaminopropyl)-N’-

ethylcarbodiimide hydrochloride (EDC·HCl), di-tert-butyl dicarbonate, and
benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium hexafluorophosphate
(BOP)

used

were

purchased

from

Advanced

ChemTech

Inc.

9-

Fluorenylmethoxycarbonyl chloride (Fmoc-Cl), N-Hydroxysuccinimide (NHS), BocHis(DNP)-OH·IPA, H-His-OMe, Boc-Ala-OH, and H-Gly-OMe were purchased from
Advanced ChemTech Inc. and used as received without further purification.
Thionyl chloride (SOCl2) was obtained from Alfa Aesar and used as received.
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Ethylene diamine (en) was received from Sigma-Aldrich. Alumina plates coated
with silica gel 60 F254 (EM, Science) were used for TLC. Reagents including
triethylamine (Et3N, TEA), trifluoroacetic acid (TFA), N,N-diisopropylethylamine
(DIPEA) and solvents were obtained from Caledon Laboratory Chemicals. All
other chemicals, including aluminum chloride (AlCl3), acetyl chloride, and 2aminopyridine were purchased from Sigma-Aldrich. Products were purified by
flash column chromatography, with 230-400 mesh silica gel (CC Grade) obtained
from Desican Inc. The esterification of Boc-His(DNP)-OH was carried out using a
modified procedure, replacing Boc-His-OH with Boc-His(DNP)-OH. NMR spectra
were recorded with a Varian Mercury VX 400 NMR spectrometer operating at
400.1 MHz (1H) and 100.6 MHz (13C). Variable temperature (VT) NMR was
carried out on a Varian INOVA 400 NMR spectrometer operating at 400.1 MHz
(1H). Chemical shifts are reported in ppm for both 1H and

13

relation to tetramethylsilane (TMS) (δ = 0). The 1H and

C NMR spectra are

C NMR spectra in

13

referenced to the CDCl3 (signals at δ = 7.27 and δ = 77.00, respectively), DMSO-d6
(signals at δ = 2.50 for 1H-NMR), ACN-d3 (signals at δ = 1.94 for 1H-NMR), and
acetone-d6 (2.05). Experiments were done at 25°C unless otherwise stated.
Coupling constants J were measured in Hz. Multiplicities are reported as follows:
s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, comp. m = complex
multiplet, app. = apparent, bs = broad singlet. Mass spectrometry analysis was
carried out using a Finnigan MAT8200 in electron impact mode (EI), Micromass
LCT (ESI) and electrospray ionization (ESI) PE-Sciex API 365 instrument by Doug
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Hairsine of the University of Western Ontario Chemistry Department. Infrared
spectra were obtained on a Bruker Tensor 27 FT-IR spectrometer. Circular
dichroism (CD) spectra were collected using a Jasco J-810 circular dichroism
spectropolarimeter in ACN, and samples were recorded under nitrogen at 20 °C.
Molar ellipticity ([θ], deg cm2 dmol-1) was calculated using equation [θ]= θobs x
10/c x l, where θobs is ellipticity measured in millidegrees, c is the concentration
of sample (10-4 M) and l is the path length of the quartz cuvette in centimeters (1
cm). Graphs were scaled by a factor of 10-2 to give a resulting unit ([θ] x 10-2 deg
cm2 dmol-1). Ellipticity maxima (λmax) are reported in nm. Metal concentration
was changed by the addition of aliquots of metal salts solutions in acetonitrile by
using μL syringes. Initial concentration of metal salt solutions were 4 mM and
aliquots of 50 μL were added in increments. Changes in concentration of host ion
were accounted for by recalculation upon dilutions.

Electrochemical

experiments were carried out at room temperature. Carbon electrode was used
as the working electrode. Platinum wire was utilized as the counter electrode.
Ag/AgCl was used as the reference electrode. Electrochemical studies were
done at a concentration of 1 mM with 0.1 M tetrabutylammonium perchlorate
(TBAP) as the supporting electrolyte in acetonitrile. All the electrodes were
washed with distilled water and acetonitrile and dried before using. Cyclic
voltammetry (CV) experiments were carried out at a scan rate of 100 mVs-1 on a
CHI 660b potentiostat at room temperature (~21±1°C). The compounds 1,1’diacetylferrocene

(Fc[COCH3]2,

52)

and
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1,1’-ferrocenedicarboxylic

acid

(Fc[CO2H]2, 53) were prepared in desired amounts according to standard
literature procedures.65-67 1,1’-ferrocendicarboxylic acid methyl ester (60)70 and
1,1’-ferrocene [CO2Me][CO2H] (61)71 were prepared according to literature
procedures.

2.2 Synthetic Procedures
2.2.1 Synthesis of Boc-His(DNP)-OMe (56)
A 100 mL round bottom flask was charged with 25 mL of dry MeOH under
nitrogen flow in which Boc-His(DNP)-OH·IPA (2.5 g, 5.2 mmol) was dissolved and
kept at 0°C. After 15 minutes at 0°C, thionyl chloride was added (0.6 mL, 8.1
mmol, 1.5 eq). After another 15 minutes, the reaction mixture was allowed to
warm to room temperature and refluxed for 48 hours. The solution was
concentrated under vacuum and was crystallized from diethyl ether to produce
compound 56. The desired product was obtained as yellow crystals in a yield of
80%, 1.5 g. 1H-NMR (400 MHz, CDCl3, 25°C) δ = 8.81 (1H, m, 3-H of DNPs), 8.57
(1H, app. ddd, J = 8.8, 2.5, 1.5 Hz, 5-H of DNPs), 7.68 (1H, d, J = 8.8 Hz, 6-H of
DNP), 7.61(1H, s, 2-im), 6.86 (s, 1H, 5-im), 5.73 (1H, d, J = 8.0 Hz, NH of NH-Boc),
4.62-4.58 (1H, m, α-H), 3.72 (3H, s, OMe), 3.15-3.03 (2H, m, CH2 of β-Hs) 1.42
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(9H, s, CH3 of Boc).

Synthesis was carried out using a modified literature

procedure replacing Boc-His-OH with Boc-His(DNP)-OH.64

2.2.2 Synthesis of Boc-His(DNP)-His(DNP)-methylester (57)
A 250 mL round bottom flask was charged with 100 mL of dry DCM in
which, Boc-His(DNP)-OH·IPA (3.3 mmol, 1.6 g) was added and dissolved with the
addition of Et3N (0.7 mL). The stirred solution was cooled to 0°C and HOBt (4.2
mmol, 0.64 g) and HBTU (4.2 mmol, 1.57 g) were added. The reaction was
removed from the ice bath and allowed to stir for 1.5 hours before the addition
of H-His(DNP)-OMe compound (2.8 mmol, 1.17 g). The reaction continued for
24 hours. The solution was then washed with aqueous sodium bicarbonate
solution 10% v/v (3 x 100 mL), then aqueous citric acid solution 10% v/v (3 x 100
mL), then sodium bicarbonate solution (3 x 100 mL), and finally with brine (3 x
100 mL). The crude residue was purified by flash column chromatography using
CHCl3 / MeOH / Et3N solvent mixture (90:9:1, Rf = 0.3); to give compound 57 as a
bright yellow powder. The product was obtained in a yield of 40%, 0.815 g. MSESI+ calculated for C30H31N10O13 [H+] = 739.2072, observed 739.2054 m/z. 1HNMR (400 MHz, CDCl3, 25°C) δ = 8.82 (s, 2H, 3-H of DNPs), 8.52 (t, J = 8.8 Hz, 2H,
5-H of DNPs), 7.75 (app. t, 2H, 6-H of DNP), 7.57 (app. d, J = 9.0 Hz, 1H, 2-im),
7.43 (app. d, J = 7.7 Hz, 1H, NH of peptide bond), 6.98 (s, 1H, 5-im), 6.94 (s, 1H, 540

im) 5.88 (d, J = 7.4 Hz, 1H, NH of NH-Boc), 4.86-4.80 (m, 1H, α-H of C-term), 4.574.51 (m, 1H, α-H of N-term) 3.71 (s, 3H, OMe), 3.22-2.98 (m, 4H, 2CfH2 of β-Hs)
1.41 (s, 9H, CH3 of Boc).

2.2.3 Synthesis of Boc-Ala-His(DNP)-OMe (58)
A 250 mL round bottom flask was charged with 150 mL of dry DCM and in
which Boc-Ala-OH (7.3 mmol, 1.4 g) was added and dissolved with the addition
of Et3N (1 mL). The stirred solution was cooled to 0°C, at which point HOBt (9.6
mmol, 3.6 g) and HBTU (9.6 mmol, 3.6 g) were added sequentially to form the
Boc-Ala-OBT active-ester in situ. The reaction mixture was removed from the ice
bath and allowed to stir for 1.5 hours before the addition of H-His(DNP)-OMe
(6.0 mmol, 2.0 g). The reaction continued for 24 hours before work up. The
solution was washed with aqueous sodium bicarbonate solution 10% v/v (3 x 100
mL), then aqueous citric acid solution 10% v/v (3 x 100 mL), then sodium
bicarbonate solution (3 x 100 mL), followed by brine (3 x 100 mL). After removal
of excess water by the addition of anhydrous sodium sulphate, the solution was
then filtered and evaporated to dryness. The crude residue was purified by flash
column chromatography using CHCl3 / MeOH (9:1 Rf = 0.29); to give compound
58 as a bright yellow powder. The product was obtained in a yield of 43%, 1.58
g. MS (EI+) Calculated for C21H27N6O9 507.18395, observed 507.1743 m/z,

1

H-

NMR (400 MHz, CDCl3, 25°C) δ = 8.83 (1H, d, J = 2.5 Hz, 3-H of DNPs), 8.57 (1H,
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dd, J = 8.7, 2.5 Hz, 5-H of DNP), 7.75 (1H, d, J = 8.7 Hz, 6-H of DNP), 7.59 (1H, s,
2-im), 7.16 (1H, app. d, NH of His), 6.95 (1H, s, 5-im), 5.18 (1H, d, J = 6.9 Hz, NH
of Ala), 4.87 (1H, dt, J = 7.8, 5.0 Hz, α-H of His), 4.25-4.15 (1H, m, α-H of Ala),
3.74 (3H, s, OCH3), 3.17 (2H, d, J = 5.0 Hz, β-H of His), 1.40 (9H, s, 3CH3 of Boc),
1.37 (3H, d, J = 7.1 Hz, CH3 of Ala).

2.2.4 Synthesis of Boc-His(DNP)-Ala-His(DNP)-OMe (59)
Boc-Ala-His(DNP)-OMe (58) (2.4 mmol, 1.23 g) was suspended in DCM (2
mL) and TFA (2 mL) was added drop wise over a period of 10 minutes. The
reaction was followed by TLC until the Boc-protected compound 58 spot was no
longer observed. The reaction flask was then cooled to 0°C and neutralized by
sequential additions of Et3N and DCM followed by rotary evaporation. The Bocdeprotected solution was added to a stirred solution of already activated in-situ
Boc-His(DNP)-OH·IPA (2.4 mmol, 1.1 g) suspended in DCM (150 mL), Et3N (1 mL) ,
HOBt (3.2 mmol, 0.5 g) and HBTU (3.2 mmol, 1.2 g), which had already reacted
for 1.5 hours. This mixture was allowed to stir for 24 hours before being worked
up. The solution was then washed with aqueous sodium bicarbonate solution
10% v/v (3 x 100 mL), then aqueous citric acid solution 10% v/v (3 x 100 mL),
then sodium bicarbonate solution (3 x 100 mL), and then with brine (3 x 100 mL).
Trace water was removed by addition of anhydrous sodium sulphate and the
solution was then filtered. After concentration by rotary evaporation, the crude
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product was purified by flash column chromatography using CHCl3 / MeOH / Et3N
solvent mixture (90:9:1, Rf = 0.24), resulting in compound 59. The product was
obtained as a deep yellow powder in a yield of 26%, 0.5 g. MS (ESI+) calculated
for C33H35N11O14 [Na+] 832.2263, observed 832.2245 m/z.

1

H-NMR (400 MHz,

CDCl3, 25°C) δ = 8.83 (m, 2H, 3-H of DNPs), 8.59-8.86 (2H, dd, J = 8.7,2.5 Hz), 7.98
(1H, d, J = 8.0 Hz, NH of Boc), 7.80 (1H, d, J = 8.7 Hz, 6-H of DNP of Boc-His), 7.76
(1H, d, J = 8.7 Hz, 6-H of DNP of His-OMe), 7.65 (1H, d, J = 1.3 Hz, 2-im), 7.62 (1H,
d, J = 1.2 Hz, 2-im), 7.15 (1H, d, J = 7.4 Hz, NH of Ala), 6.96 (1H, d, J = 1.2 Hz, 5im), 6.94 (1H, d, J = 1.2 Hz, 5-im), 5.93 (1H, d, J = 6.9 Hz, NH of His), 4.82 (1H, m,
α-H of N-term His), 4.50 (1H, q, J = 7.4 Hz, α-H of Ala), 4.42 (1H, m,α-H of C-term
His), 3.73 (3H, s, OMe), 3.13 (4H, m, β-CH2 of His) 1.41 (9H, s, 3CH3 of Boc), 1.30
(3H, d, J = 7.2 Hz, CH3 of Ala).

2.2.5 Synthesis of compound 4, 1,1’-Fc[CO2Me][CONHC2H4NHBoc] (62)
Fc[COOMe][COOH] 61 (2.0 mmol, 0.58 g) was suspended in DCM(150 mL)
and Et3N (2 mL). This was allowed to stir for 30 min before addition of HOBt (2.6
mmol, 0.41 g) and EDC (2.6 mmol, 0.50 g). This stirred for 1.5 hours before a
solution of Boc-ethylenediamine (2.4 mmol, 0.38 g) and DCM (50 mL) was added.
The progress of the reaction was followed by TLC until completion using
EtOAc:Acetone (7:2) as the mobile phase. The compound was purified by flash
chromatography EtOAc:Acetone (7:2 Rf = 0.54). The product was obtained as an
orange powder, in a yield of 0.320g, 37%. MS-EI: calculated for C20H26N2O5Fe
43

430.1191, observed 430.1193 m/z. 1H-NMR (400 MHz, CDCl3, 25°C) δ = 6.60 (1H,
m, NH of Fc), 5.40 (1H, m, NH of Boc), 4.75 (2H, s, ortho-H of Fc), 4.63 (2H, s,
ortho-H of Fc), 4.43 (2H, m, meta-H of Fc), 4.35 (2H, m, ortho-H of Fc), 3.83 (3H,
s, CH3 of OMe), 3.49 (2H, app. q, CH2 of en), 3.37 (2H, app. q, CH2 of en), 1.44
(9H, s, 3CH3 of Boc). 1H-NMR (400 MHz, acetone-d6, 25°C) δ = 7.32 (1H, m, NH of
Fc), 6.10 (1H, m, NH of Boc), 4.83 (2H, t, J = 1.8 Hz, ortho-H of Fc), 4.76 (2H, t, J =
1.8 Hz, ortho-H of Fc), 4.44 (2H, t, J = 1.8 Hz, meta-H of Fc), 4.36 (2H, t, J = 1.8 Hz,
meta-H of Fc), 3.78 (3H, s, OCH3), 3.49 (2H, q, J = 3.6 Hz, CH2 of en), 3.37 (2H, q, J
= 3.6 Hz, CH2 of en), 1.40 (9H, s, 3CH3 of Boc).

13

C NMR (100.6 MHz, CDCl3) δ

171.91, (C=O of ester), 169.77 (C=O of CONH), 166.02 (C=O), 157.07 (C=O of
Boc), 79.53, 78.05 (C of Fc attached to C=O), 72.97 (Ci of Fc), 72.21 (ortho-C of
Fc), 71.95 (ortho-C of Fc), 71.75 (meta-C of Fc), 70.19 (meta-C of Fc), 52.12 (CH3
of ester), 40.91, 40.76 (NH-CH2) 38.73 (tertiary C of Boc), 28.55 (C of Boc-CH3).

2.2.6 Synthesis of 1,n’-Fc[COOH][CONHC2H4NHBoc] (63)
Fc[COOMe][CONHC2H4NHBoc] (62) (1.0 mmol, 0.43 g) was suspended in
THF (75 mL) and H2O(3 mL), followed by the addition of LiOH (2.0 mmol, 0.048
g). This was allowed to stir overnight. The compound was washed with ether to
remove starting material before the addition of 10% citric acid solution (200 mL).
The product was extracted into ethyl acetate. The product was a red powder
obtained in a yield of 56%, 0.24 g. MS-EI: calculated for C19H24N2O5Fe 416.1035,
44

observed 416.1041 m/z. 1H-NMR (400 MHz, acetone-d6, 25°C): δ = 7.41 (1H, s,
NH of Fc), 6.26 (1H, s, NH of Boc), 4.79 (2H, s, ortho-H of Fc), 4.76 (2H, t, J = 1.8
Hz, ortho-H of Fc), 4.47 (2H, t, J = 1.8 Hz, meta-H of Fc), 4.39 (2H, t, J = 1.8
Hz,meta-H of Fc), 3.42 (2H, q, J = 5.8 Hz, CH2 of en), 3.28 (2H, q, J = 5.8 Hz, CH2 of
en) 1.42 (9H, s, 3CH3 of Boc).

2.2.7 Synthesis of 1,n’-Fc[CO-L-His-OMe][CONHC2H4NHBoc] (64)
Fc[COOH][CONHC2H4NHBoc] (63) (0.5 mmol, 0.2 g) was suspended in dry
DCM (70 mL) followed by the addition of Et3N (0.16 mL), HOBt (0.6 mmol, 0.09
g), and HBTU (0.6 mmol, 0.22 g). This was allowed to stir for 1.5 hours before
addition of L H-His-OMe (0.6 mmol, 0.141 g) and additional Et3N (0.16 mL). This
was allowed to stir for 3 days before it was worked up. The work up consisted of
washing with aqueous 10% v/v NaHCO3 solution and water. The crude
compound was then purified by flash chromatography DCM / MeOH (9:1 Rf =
0.1). The compound was obtained as yellow powder in a yield of 10%, 0.02 g. MS
(EI+) mass calculated for C26H33FeN5O6 567.1771, obtained 567.1780 m/z. FT-IR
(KBr, cm-1): 3330 (H-bonded amide A), 1740 (C=O), 1692 (amide I), 1639
(amide I), 1541 (amide II). 1H-NMR (400 MHz, CDCl3, 25°C) δ = 8.14 (1H, s, NH of
His), 7.63 (1H, s, H of 2-im), 7.29 (1H, s, NH of en near Fc), 6.89 (1H, s, 5-im), 6.07
(1H, s, NH of Boc), 4.88 (1H, s, α-H of His), 4.69 (2H, app. d, ortho-H of Cp), 4.64
(2H, s, ortho-H of Cp), 4.42 (2H, s, meta-H of Cp), 4.37 (2H, app. d, meta-H of Cp),
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3.64 (1H, s, 1-β CH of His), 3.21 (5H, m, 2CH2 of en, 1 βH of His), 1.44 (9H, s, 3CH3
of Boc).
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C NMR (δ = ppm, 100.1 MHz, CDCl3) δ = 172.79 (CO2Me), 170.77,

170.65 (C=O attached to Fc), 156.95 (CO of Boc), 135.44 (1-im), 134.74 (3-im),
116.03 (4-im), 79.27 (tertiary C of Boc) , 77.68 (Ci of Fc), 77.37 (Ci of Fc), 76.56,
71.84 (C-ortho of Fc), 71.84 (C-ortho of Fc), 71.56 (C-ortho of Fc), 71.51 (C-ortho
of Fc), 71.36 (C-meta of Fc), 71.17 (C-meta of Fc), 70.78 (C-meta of Fc), 70.15 (Cmeta of Fc), 53.25 (αC of His), 52.71 (OCH3), 40.76 (CH2 of en), 40.40 (CH2 of en),
28.59 (Boc H3C), 28.48 (OCH3).

2.2.8 Synthesis 1,n’-Fc [CO-Ala-His(DNP)-OMe][CONHC2H4NHBoc] (65)
Fc[CONHC2H4NHBoc][CO2H] (63) (0.7 mmol, 0.274 g, 1.0 eq) was
suspended in dry DCM (50 mL) and Et3N (0.2 mL), to which the in situ OBT activeester was formed using EDC·HCl (1.2 eq, 0.79 mmol, 0.15 g) and HOBt (1.2 eq,
0.79 mmol, 0.12 g). After 1.5 hours NH2-Ala-His(DNP)-OMe (0.79 mmol, 1.2 eq)
was added to the reaction mixture and it was allowed to stir for 2 days at room
temperature. The reaction mixture was purified by silica gel chromatography
using 3% MeOH in CHCl3 (Rf = 0.15). The compound was dried by rotary
evaporation to afford an orange solid. The desired product was obtained in a
yield of 14%, 0.07 g. FT-IR (KBr, cm-1): 3300 (amide A), 1692 (amide I), 1639
(amide I), 1541 (amide II) , 1504 (amide II) MS (ESI+) calculated for
C35H41FeN8O11[H+] = 805.2244, obtained [H+] 805.2211 m/z. 1H-NMR (400 MHz,
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CDCl3, 25°C) δ = 8.81 (1H, app. d, 3-DNP), 8.54 (1H, d, J = 7.7 Hz, 5-DNP), 7.80
(1H, d, J = 8.6 Hz, 6-DNP), 7.57 (1H, s, NH His) 7.52 (1H, s, 2-im), 7.12 (1H, app. d,
NH of Ala), 7.07 (1H, s, 5-im), 5.68 (1H, s, NH of Boc), 4.89 (1H, m, α-H of His),
4.60 (2H, s, Cp), 4.56 (1H, α-H of Ala), 4.41 (1H, s, Cp), 4.34 (1H, s, Cp), 4.32 (1H,
s, Cp), 4.29 (2H, s, Cp), 3.75 (3H, s, OCH3), 3.48 (2H, m, CH2 of en), 3.32 (2H, m,
CH2 of en), 3.22 (2H, d, J = 5.3 Hz, 2β-H of His), 1.51 (3H, d, J = 7.0 Hz, CH3 of Ala),
1.41 (9H, s, 3CH3 of Boc). 1H-NMR (400 Mhz, ACN-d3, 25°C): 8.74 (1H, d, J = 2.2
Hz, 3-DNP), 8.51 (1H, dd, J = 2.2, 8.6 Hz, 5-DNP), 7.78 (1H, d, J = 8.6 Hz, 6-DNP),
7.71 (1H, d, J = 7.0 Hz, NH of His), 7.65 (1H, s, 2-im), 7.16 (1H, d, J = 7.0 Hz, 1H of
Ala), 7.13 (1H, s, 5-im), 7.10 (1H, s, NH of Fc), 5.97 (1H, s, NH-Boc), 4.73 (1H, m,
α-H of His), 4.63 (2H, s, ortho-Fc), 4.62 (1H, s, ortho-Fc), 4.58 (1H, s, ortho-Fc),
4.46 (1H, m, α-H of Ala), 4.38 (4H, s, meta-Fc), 3.67 (3H, s, OCH3), 3.39 (2H, m,
CH2 of linker), 3.23 (2H, m, CH2 of linker), 3.09 (2H, d, J = 8.5 Hz, β-H His), 1.40
(3H, app. d, CH3 of Ala), 1.38 (9H, s, Boc).

13

C-NMR (CDCl3): 173.21 (CO of Ala),

171.59 (CO of His), 170.68 (CO of Fc), 170.28 (CO of Fc), 156.99 (CO of Boc),
146.90 (4-DNP), 144.29 (2-DNP), 139.84 (1-DNP), 136.53 (2-im), 135.18 (4-im),
129.35 (5-DNP), 128.46(6-DNP), 121.43(2-DNP), 117.88(4-im), 79.70 (tertiary C of
Boc), 78.10 (Cp), 77.36 (Cp), 71.61 (Cp), 71.56 (Cp), 71.40 (Cp), 70.79 (Cp), 70.62
(Cp), 70.25 (Cp), 52.72 (OCH3), 52.30 (α-H His), 49.46 (α-H Ala), 41.46 (CH2 of en),
41.04 (CH2 of en), 29.78 (β-H of His), 28.58 (Boc CH3), 18.22 (CH3 of Ala).
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2.2.9 Synthesis of 1,n’-Fc[COOMe][CONHC2H4NH-His(Boc)Boc] (66)
To a solution of Fc[CO2OMe][CONHC2H4NH-Boc] (62) (2 mmol, 0.900 g) in
DCM (2 mL), 1 mL of TFA was added and this was allowed to stir for 1 hour. The
reaction was quenched with Et3N until basic pH was reached with 2 mL Et3N. This
was reduced by rotary evaporation and was added to a solution of HOHis(Boc)Boc (2.3 mmol, 0.816 g), HBTU (2.3 mmol, 0.872 g), HOBt (2.3 mmol,
0.312 g), and 0.5 mL of Et3N. This reaction stirred for 2 days at room
temperature, purified by silica gel chromatography using a 3% MeOH solution in
CHCl3 (Rf = 0.15). The solution was dried by rotary evaporation to afford an
orange powder, compound 66. The produced was obtained in a yield of 30%,
0.036g. MS (ESI+) calculated for C35H41FeN8O11[H+] 667.2, observed 667.2 m/z.
1

H-NMR (400 MHz, CDCl3, 25°C) δ = 7.94 (1H, s, H of 2-im), 7.14 (1H, s, H of 5-im),

6.93 (1H, s, NH nearest to Fc), 6.55 (1H, app. t, NH of His), 6.05 (1H, s, NH of
Boc), 4.69 (2H, s, ortho-H of Cp), 4.63 (2H, s, ortho-H of Cp), 4.38 (2H, app. d,
meta-H of Cp), 4.33 (1H, s, α-H of His), 4.30 (2H, s, meta-H of Cp), 3.77 (3H, s,
OCH3), 3.30 (2H, m, CH2 of en), 3.22 (2H, m, CH2 of en), 2.92 (2H, m, β-CH2), 1.53
(9H, s, 3CH3 of Boc), 1.36(9H, s, 3CH3 of Boc).

2.2.10 Synthesis of 1,1’- Fc dicarbonyl chloride (67)
Synthesis was carried out according to a literature procedure.69 A 100 mL
round bottom flask containing 50 mL dry DCM and 0.5 mL Et3N under nitrogen
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flow, Fc[COOH]2 53 (0.5 g, 1.8 mmol) was dissolved and cooled to 0°C. Then
oxalyl chloride (0.5 mL, 2.66 mmol) was slowly added and brought to room
temperature after 15 minutes. Following this, the solution was allowed to stir
for 6 hours. The bright red solution was concentrated by rotary evaporation
until a deep red crude product was observed. The crude product was further
purified by recrystalization using warm petroleum ether. The resulting crystals
were then filtered, collected and obtained as deep red crystals in a yield of 70%,
4.0 g. MS-EI Calculated mass for C12H8Cl2O2Fe 309.92508, obtained 309.92508
m/z.

1

H-NMR (400 MHz, CDCl3, 25°C), 5.06 (4H, s, Cp), 4.68 (4H, s, Cp).

2.2.11 Synthesis of 1,n’-Fc[CO-Ala-His(DNP)-OMe]2 (68)
Fc[COOCl]2 (67) (0.12 g, 0.4 mmol, 1 eq) was dissolved in DCM (15 mL),
and DIPEA (0.2 mL) was added. This solution was cooled to 0°C and Boc deprotected Ala-His(DNP)-OMe (0.8 mmol, 2 eq) was slowly added. This solution
was allowed to stir for 4 hours, then washed with aqueous 10% v/v sodium
bicarbonate solution (3 x 100 mL), then aqueous citric acid solution 10% v/v (3 x
100 mL), then sodium bicarbonate solution (3 x 100 mL), then with brine (3 x 100
mL). Trace water was removed by the addition of anhydrous sodium sulphate.
The solution was then filtered and concentrated. The crude product was purified
by silica gel chromatography using a 7% MeOH solution in CHCl3 (Rf = 0.22). After
drying, the compound was obtained as a red powder with a crude yield of 1%,
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0.01 g. MS (ESI+) calculated for C44H43FeN12O16 [H+] = 1051.2269, observed
1051.2 m/z. 1H-NMR (400 MHz, CDCl3, 25°C), δ = 8.83-8.80 (2H, m, 3-H of DNP),
8.57 (2H, m, 5-H of DNP), 8.24 (1H, m, 2-im), 8.08 (1H, m, 2-im), 7.73-7.74 (2H,
m, 6-H of DNP), 7.46 (2H, m, NH of His), 7.05 (1H, app. d, 5-im), 7.01 (1H, app. d,
5-im), 6.82 (2H, app. d, NH of Ala), 5.50 (2H, m, α-H His), 4.86 (2H, m, ortho-H of
Fc), 4.77 (2H, m, ortho-H of Fc), 4.62 (2H, m, meta-H of Fc), 4.59 (2H, m, meta-H
of Fc), 4.27 (2H, m, α-Ala), 3.75 (3H, s, OCH3), 3.13 (4H, m, βH of His), 1.25 (3H,
m, CH3 of Ala).

2.2.12 Synthesis of 1,n’-Fc [COOBt][CONHC2H4NHFmoc] (69)
Fc[COOH]2 (2) (1 eq, 1.8 mmol, 0.501 g) was suspended in DCM (150 mL),
followed by the addition of DIPEA (2.5 eq, 5.5 mmol, 0.700 g) and HOBt (2.5 eq,
4.6 mmol, 0.700 g) was added. This was allowed to stir for 2 hours before the
addition of ethylenediamine-Fmoc (1 eq, 1.8 mmol, 0.700 g). This stirred for 12
hours before it was worked up. The work up consisted of washing with saturated
NaHCO3 solution, 10% citric acid solution, saturated NaHCO3 solution, and finally,
water. The compound was purified by flash chromatography using ethyl acetate
as the mobile phase (Rf = 0.2). The product was obtained as a deep red powder,
and obtained in a yield of 20%, 0.24 g. 1H-NMR (400 MHz, CDCl3, 25°C), δ = 8.06
(1H, d, J = 8.4 Hz, H of OBt), 7.74 (2H, d, J = 7.6 Hz, 2H of Fmoc), 7.55 (4H, m, 2H
of Fmoc, 2H of OBt), 7.43 (1H, s, H of OBt), 7.37 (2H, t, J = 7.9 Hz, 2H of Fmoc),
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7.30-7.21 (2H, m, 2H of Fmoc), 6.81 (1H, app. t, NH of N attached to Fmoc), 5.62
(1H, app. t, NH nearest to Fc), 5.03 (2H, m, Cp of Fc), 4.94 (2H, m, Cp of Fc), 4.74
(2H, m, Cp of Fc), 4.58 (2H, m, Cp of Fc), 4.29 (2H, d, J = 7.2 Hz, CH2 of Fmoc),
4.12 (1H, t, J = 6.6 Hz, CH of Fmoc), 3.51 (2H, dd, J = 10.4, 4.5 Hz, CH2 of en), 3.36
(2H, dd, J = 10.4, 5.2 Hz, CH2 of en).

2.2.13 Synthesis of 1,n’-Fc[CO-Gly-OMe][CONHC2H4NHFmoc] (70)
1,n’-Fc [COOBt][CONHC2H4NHFmoc] (69) (0.1 mmol, 0.065g) was
suspended in DCM (30 mL) and DIPEA (0.15 mmol, 0.02 g) was added. The
suspension was chilled on ice for 30 minutes before the addition of H-Gly-OMe
(0.11 mmol, 0.01 g). This was allowed to stir for 48 hours before being purified
by column chromatography using ethyl acetate as the mobile phase (Rf = 0.21).
The product was an orange powder and the yield was 90%, 0.009 g. 1H-NMR (400
MHz, CDCl3, 25°C), δ = 7.74 (2H, d, J = 7.4 Hz, 2H of Fmoc), 7.61 (2H, d, J = 7.5 Hz,
2H of Fmoc), 7.38 (2H, t, J = 7.7 Hz, 2H of Fmoc), 7.28 (3H, m, 2H of Fmoc, 1H of
NH carbamate), 6.99 (1H, s, NH of Gly), 6.18 (1H, s, NH of en next to Fc), 4.73
(2H, s, Cp of Fc), 4.56 (2H, s, Cp of Fc), 4.42 (2H, s, Cp of Fc), 4.39 (2H, app. d, α-H
of Gly), 4.35 (2H, s, Cp of Fc), 4.22 (1H, app. t, CH of Fmoc), 4.11 (2H, app. d, CH2
of Fmoc), 3.78 (3H, s, OMe), 3.52 (2H, m, CH2 of en), 3.43 (2H, m, CH2 of en).
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CHAPTER 3: Results and Discussion
3.1 Peptide synthesis
This chapter deals with the synthesis and characterization of a series of histidinecontaining ferrocene conjugates, their spectroscopic and structural properties and their
abilities to coordinate to a range of metal ions. Initially, histidine-rich peptides were
synthesized as outlined in Scheme 3.1.1. The route that was employed started with an
Nterm-protected Boc-His(DNP)-OH (56) which was then Cterm-protected by way of methyl
ester formation.67 The compound was then Boc deprotected on the Nterm, by way of TFA.
This was followed by coupling to Boc-Ala-OH or Boc-His(DNP)-OH, using HBTU coupling
reagent in the presence of HOBt and the base triethylamine (Et3N). The dipeptide
product was purified using silica gel column chromatography using CHCl3 / MeOH / Et3N
as the mobile phase or CH2Cl2 / MeOH as the mobile phase to achieve Rfs of 0.3 (CHCl3 /
MeOH / Et3N 90:9:1) for Boc-His(DNP)-His(DNP)-OMe(57) and 0.29 (CH2Cl2/MeOH 95:5)
for Boc-Ala-His(DNP)-OMe (58). The tripeptide Boc-His(DNP)-Ala-His(DNP)-OMe (59) was
synthesized using standard deprotection and coupling methods, starting from 58.
Peptides were obtained in moderate yields (35-50%) and their identities were confirmed
using ESI-MS, 1H-NMR and gCOSY. Figure 3.1.1 shows a partial 1H-NMR spectrum for
compound 58, as a representative example. 2D-COSY experiments were used to
complete assignments in the 1H-NMR spectra. A resonance was observed at 7.16 ppm,
having cross correlations with 4.87 ppm, which have further cross correlations at 3.17
ppm (Figure 3.1.2). These signals have integrations of 1:1:2 respectively. The resonance
at 7.16 ppm is confirmed to be the amide proton of histidine, which has a diagnostic
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doublet resulting from coupling with the α-proton. The signal at 4.87 ppm is the αproton which is a doublet of triplets, and 3.17 ppm corresponds to the β-protons of
histidine, a doublet seen in Figure 3.1.2. The protons of alanine are observed at 5.18,
4.20 and 1.37 ppm. The signal at 1.37 ppm shows cross correlation with the α-proton at
4.20 ppm and displays the expected integrations of 1:1:3, respectively. This confirms δ =
5.18 ppm is the amide of alanine, 4.20 ppm corresponds to the α-proton, and 1.37 ppm
corresponds to the CH3 of Ala.

Scheme 3.1.1 Synthesis of peptides (56-59) i) SOCl2, MeOH ii) TFA/CH2Cl2 iii) HOBt,
HBTU, Et3N, Boc-His(DNP)-OH iv) HOBt, HBTU, Et3N, Boc-Ala-OH v) TFA/CH2Cl2 vi) HOBt,
HBTU, Boc-His(DNP)-OH.
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β

2

1 α1

α2

Figure 3.1.1 Compound 58 Boc-Ala-His(DNP)-OMe, and partial 1H-NMR
H
and expansion
showing amide N-H,
H, α-H,
α β-Hs
Hs of histidine residue in the dipeptide the amide doublet at
δ = 7.16 ppm,, the doublet of triplets
tripl at 4.87 ppm assigned to the α-H,
α and the doublet at
3.17 ppm corresponding to the two β
β-Hs.

Figure 3.1.2 1H-NMR gCOSY spectrum of compound 58 displaying the proton-proton
cross coupling of the
he amide, α-protons
α
, and β-protons from His and Ala.
Ala
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The 1H-NMR analyses
a
of compounds 56-59 were carried out and the 1H-NMR
overlay of them is displayed in Figure
F
3.1.3. Additionally, selected
elected analytical details of
compounds 57-59 are summarized in Table 3.1.1.

Boc-His(DNP)-Ala-His(DNP)-OMe (59)

*

Boc-His(DNP)-His(DNP)-OMe (58)

Boc- Ala-His(DNP)-OMe (57)

Boc- His(DNP)-OMe (56)

Figure 3.1.3 1H-NMR
NMR overlay of LL-series of peptides (56-59),
), illustrating the downfield
shift of amide proton position as a function of peptide unit increase. This amide shift
indicates the stronger tendency of the amide proton to be involved in hydrogen
bonding. 1H-NMR
NMR were run at a concentration of 10 mM in CDC
CDCl3.
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Table 3.1.1 Selected mass spectrometric (ESI-MS) and NMR spectroscopic data (CDCl3
solution) for peptides (57-59).
Compound

Cal. Mass
Found (calc.)

NH 1H-NMR
(ppm)

α-H 1H-NMR
(ppm)

Boc-His(DNP)-His(DNP)OMe(57)

[M]+
739.2072 (739.2054)

7.47, 5.90

4.81, 4.53

Boc-Ala-His(DNP)-OMe (58)

[M]+
506.1743 (506.1761)

7.16, 5.18

4.87, 4.20

Boc-His(DNP)-Ala-His(DNP)OMe (59)

[M+Na]+
832.2263(832.2245)

7.89, 7.15,
5.93

4.82, 4.50,
4.42

3.2 Syntheses of ferrocene-conjugate scaffold.
The diamine linker, ethylene diamine was chosen for its short length because it
adds needed flexibility and coordination properties to the ferrocene scaffold.
Conjugation to Fc[CO2H][CO2Me] using standard coupling procedures resulted in
conjugate 62. The methyl ester of conjugate 62 was deprotected using LiOH to yield 63.
Compound 63 was used as the scaffolding unit at a later time. Previous studies by
Drexler et al. found that shorter diamine linkers resulted in a higher degree of hydrogen
bonding interactions.52
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Scheme 3.2.1 Overall synthetic strategy for preparation of compounds 62 and 63.
Reagents and conditions: i) AlCl3, CH3COCl, DCM; ii) Bleach, Δ; iii) MeOH, H2SO4, Δ; iv)
MeOH, Me2CO, NaOH; v) NH2(CH2)2NHBoc, HBTU, HOBt, TEA, DCM; vi) THF,LiOH. 66,67

Synthesis of compound 62 was carried out using the coupling reagent HBTU, in
the presence of HOBt under basic conditions. Regardless of reaction time or amine
equivalents, the overall yield of 62 never exceeded 35%. The crude product was purified
using silica gel with EtOAc, Me2CO (7:1) as the mobile phase. Under these conditions
conjugate 62 has an Rf of 0.54. Since compound 63 is not soluble in CDCl3, both 62 and
63 1H-NMR spectra used acetone-d6 as the solvent for comparison. In the 1H-NMR
spectrum of 62, the chemical shifts of the amide protons were observed at 7.41 and 6.30
ppm. The signal at 7.41 ppm corresponds to the NH nearest to Fc and the signal at 6.30
ppm corresponds to the NH of the carbamate. Four signals for the Fc protons were
observed in the expected ratio of 1:1:1:1.69-70 The methyl ester proton signals were
observed at 3.78 ppm. Upon hydrolysis of the methyl ester using LiOH in THF affixed 63
in 56% yield. The methyl ester resonance observed at 3.78 ppm of 62 is now absent,
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confirming successful hydrolysis of the ester.
ester The analytical details of these compounds
compound
are summarized in Table 3.2.1.

Boc

1 3

4 2
Fc
34

Acetone

2

1

1 3
4

OMe

2
Fc

Boc

H2O
3 4

1

2

Acetone

Figure 3.2.1 1H-NMR
NMR spectrum of 1,1’
1,1’-Fc[CONH(CH2)2NHBoc][CO
Boc][CO2Me] (62) and 1,n’Fc[CONH(CH2)2NHBoc][CO
Boc][CO2H] (63). (20 mM, acetone-d6.)

The electrochemical properties of compounds 62 and 63
6 were studied using
cyclic voltammetry in acetonitrile. The results are summarized in Table 3.2.1
3.2 and the CVs
of compound 62 and 63 are shown in Figure 3.2.2. These conjugates show reversible
electrochemical behaviour and their anodic-to-cathodic
cathodic Faradaic current ratios (ia/ic) are
close to 1. The half-wave
wave potentials (E1/2) are 0.743 and 0.741 respectively. This is typical
behaviour for Fc peptide conjugates.
conjugates 51-57
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Table 3.2.1 Select analytical data for compounds 62 and 63.
Compound

Mass Found
(m/z)

Mass Calc.

NH 1H-NMR
H
(ppm)

Cp 1H-NMR
(ppm)

62

430.1193

430.1191

7.31, 6.10

63

416.1041

416.1035

7.41, 6.30

4.81, 4.77,
4.47, 4.39
4.83, 4.74,
4.45, 4.36

Table 3.2.2 Electrochemistry
Electroche
data of 1 mM conjugates 62 and 63
3 in acetonitrile (1mM
compound, 0.2M TBAPF6. vs Ag/AgCl. Scan rate = 100mVs-1, glassy carbon as working
electrode, Pt wire as counter electrode, and Ag/AgCl as reference electrode).
Compound
ompound

E1/2(V)

ΔEp (V)

(ia/ic)

62
63
3

0.743(5)
0.741(5)

0.095
0.093

0.94
0.92

63

62

Figure 3.2.2 Cyclic voltammograms of compounds 62 (left), 63 (right) in CH3CN (1mM
compound),, 0.2M TBAPF6. vs Ag/AgCl. The scan rate was = 100mVs-1, a glassy carbon as
working electrode was used
used, and a Pt wire was used as the counter electrode, and
Ag/AgCl was used for a reference electrode. The initial scan direction was anodic starting
at 0.4 V and it switched to a cathodic potential at 1.1 V.

Compound 62 was crystallized by slowly diffusing hexanes into a CHCl3 solution
at room temperature, yielding orange needle-like crystals.. Single-crystal
Single
analysis

59

revealed a structure with the amine linker protruding outwards. Figure 3.2.3 shows an
Oak Ridge Thermal Ellipsoid Plot (ORTEP) representation of compound 63.

Figure 3.2.3 ORTEP representations of compound 62. Thermal ellipsoids are depicted at
50% probability. The hydrogen atom positions were calculated geometrically and are
included as riding on their respected atoms.

Compound 62 crystallizes in the monoclinic space group P21 with two molecules
per unit cell. The Cp rings are close to eclipsed with a torsion angle between the ring
substituents of -0.96° indicating that it adopts the 1,1’ conformation.44 The amide group
of 62 is tilted at 10.01° with respect to the Cp ring. The Cp rings themselves are tilted
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0.81° out of coplanarity. There are no intramolecular hydrogen bonds in 62, however,
the molecules do engage in intermolecular hydrogen bonding (Figure 3.2.4). The
intermolecular hydrogen bonding involves the interaction between the carbonyl of O(1)
and N(2)’ of the amide at the opposite end of the adjacent molecule d(N2···O1) distance
= 2.885(4) Å. Involvement in hydrogen bonding does not appear to change the length of
the C=O bond distance significantly. The C=O bond distance of the hydrogen bonded
carbonyl is d(C6···O1) = 1.233(3) Å, compared to that of the non-hydrogen bonded
carbonyl groups d(C10···O3) = 1.219(3) Å and d(C19···O4) = 1.196(3) Å.

Table 3.2.3 Select bond distances for compound 62.
Bond Distances
O(1)-N(2)
O(1)-C(6)
O(3)-C(10)
O(4)-C(19)
N(1)-C(6)
N(2)-C(10)
Cp (centr.)-Cp(centr.)

62
2.885(4)
1.233(3)
1.219(3)
1.196(3)
1.329(4)
1.361(4)
3.304(11)

Table 3.2.4 Select angles for 62.
Angles
62
Angle between ring substituents (ω)
2.21°
Tilt angle of Cp rings (θ)
0.81°
Angle between Cp and amide (β)
10.11°
Angle between Cp and ester (β)
1.55°
Refer to Figure 3.2.4 for visualizations of angles ω, θ and β.
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Table 3.2.5 Crystallographic data
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Chemical Formula
Formula mass
Crystal colour
Crystal size/mm
Crystal system
Space group
Hall group
a/Å
b/ Å
c/ Å
α/°
β/°
γ/°
V (Å3)
Z
Density calculated, g/cm3
Temperature (K)
θ max (°)
Radiation (Å)
μ/mm-1

C20 H26 Fe N2 O5
430.28
Orange
0.23 x 0.16 x 0.14
monoclinic
P21
P2yb
12.5371(10)
6.7555(4)
13.6054(10)
90
98.698(4)
90
970.44 (13)
2
1.472
150
28.240
Mo-Kα λ = 0.71073
0.812

F(000)
2Θ range for data collection
Total reflections
Independent reflections
Fcalc
Parameters
S (Goodness-of-fit)
R1 [Io > 2σ(Io)]
wR2
Flack Parameter

452.0
3.02 to 56.48°
4635
2648
1987
253
0.994
0.0391
0.0887
0.075(15)

Figure 3.2.4 Some important structural parameters of Fc peptides are shown and include
the torsion angle ω between the two peptides, the tilt angle θ between the two Cp rings
and the twist angle β between the Cp ring and the amide plane.
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Figure 3.2.5 Mercury representations of 62 illustrating intermolecular hydrogen bonding
(dashed blue line) between O(1) and N(2)’ of adjacent molecules. Hydrogen atoms have
been omitted for clarity.
Looking at the crystal structure, the compound appears to crystallize in a sheetlike structure. A similar sheet structure has also been observed in the compound 1,1’ureylenedi (1-ferrocenecarboxylate) (71), a by-product in the synthesis of 1-amino1’ferrocenecarboxylic acid.66,74 The intermolecular hydrogen bonding of 71 is shown in
Figure 3.2.6. In the crystal structure of 71, the hydrogen bonding is asymmetric with one
intermolecular hydrogen bond between the methyl ester substituent of one Cp ring to
the urea amide of an adjacent molecule with a N···O distance of 2.819(3) Å.74
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Figure 3.2.6 Crystal packing of dimethyl 1,1’-urealenedi(1-ferrocenecarboxylate) (71)
showing the intermolecular hydrogen bonding interactions between the methyl ester
carbonyl and the urea NH of an adjacent molecule. Material reproduced from Ref. 74
with permission from Elsevier.

Table 3.2.6 Select bond distances for compound 71.
Bond Distances
O(21)’-N(11)
O(11)–C(15)
O(25)-C(21)
O(41)-C(45)
N(12)–C(30)
N(11)–C(10)
N(11)–C(15)
N(12)–C(15)
O(11)–C(15)
Cp (centr.)-Fe1-Cp(centr.)
Cp (centr.)-Fe2-Cp(centr.)

71
2.819(3)
1.329(4)
1.231(4)
1.211(3)
1.196(3)
1.395(3)
1.367(3)
1.378(3)
1.329(4)
3.316(10)
3.316(10)
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Table 3.2.7 Select angles for 71.
Angles
Angle between ring substituents (ω)

71
(Fc1)
22.03°
(Fc2)
7.31°
Tilt angle of Cp rings(θ)
(Fc1)
2.14°
(Fc2)
3.95°
Angle between Cp and urea (β)
(Fc1)
17.43°
(Fc2)
0.61°
Angle between Cp and ester (β)
(Fc1)
3.96°
(Fc2)
10.29°
Refer to Figure 3.2.4 for visualizations of angles ω, θ and β.

Tables 3.2.6 and 3.2.7 list select bond distances and angles for compound 71.
Both crystal structures of compounds 62 and 71 engage in intermolecular hydrogen
bonding between the N amide of one strand and the adjacent carbonyl of an adjacent
molecule. However, they differ in hydrogen bonding acceptor sites. In 62, the hydrogen
bonding acceptor is the carbonyl of an amide bond, and 71 is the carbonyl of an ester.
They also differ in hydrogen bonding distances. Compound 71 has a much shorter N···O
distance of 2.819(3) Å compared to 62 with an N···O distance of 2.885(4) Å. Both
compound 62 and 71 show a similar length of the C=O that is acting as the hydrogen
bond acceptor, of d(O1···C6) = 1.233(3) Å and d(O25···C21) = 1.231(4) Å respectfully. The
length of the C-N bond for the hydrogen bond donors in these molecules are also
similar; 62 which have N···C length of d(N3···O10)= 1.361(4) Å and 71 with a length of
d(N11···C15) = 1.367(3) Å. These crystal structures display a similar hydrogen bonding
sheet-like pattern and share some common structural features like bond lengths.
However, these molecules also demonstrate differences in geometry. For example, the
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tilt angles between the ring substituents (ω) are significantly different with 62 having an
angle of 2.21˚ and 71 having angles of 22.03˚ and 7.31˚.

3.3 Synthesis and characterization of Fc[CO-His-OMe][CONHC2H4NHBoc]
Histidine was conjugated to 63 to examine the possibility of controlling metal
coordination through the imidazole ring and ethylene diamine fragment. In a one-pot
reaction, the carboxylic acid group on the Fc scaffold (63) was first activated with N-(3dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) coupling reagent in the
presence of 1-hydroxybenzotriazole (HOBt) and H-His-OMe was added in the presence
of Et3N to yield Fc[CO-His-OMe][CONHC2H4NHBoc] (64). Conjugate 64 was then purified
by silica gel chromatography using CH2Cl2 / MeOH (9:1) as the mobile phase, with an Rf
of 0.1. Conjugate 64 was obtained as a yellow powder in a yield of 10%.

Scheme 3.3.1 Synthesis 1,n’-Ferrocene [CO-L-His-OMe][CONHC2H4NHBoc] (64), (i)
Fc[CONHC2H4NHBoc][CO2H](63) was activated by HBTU/HOBt in the presence of Et3N
(ii) addition of His-OMe + Et3N and allowed to react for 72 hours.
The identity of compound 64 was confirmed using 1H-NMR and

13

C-NMR

spectroscopy and electrospray ionization mass spectrometry (ESI-MS). In the 1H-NMR
spectra, the Fc protons were observed in 1:1:2:2:1:1 ratio (See Figure 3.3.1), because
66

this molecule is asymmetric.
asymmetric This splitting pattern is similar to other asymmetric 1,n’ Fc
peptide conjugates.43 It should also be noted that the chemical shift of the 4 ortho
protons in 64 were shifted downfield compared to the 4 meta-protons.
protons.42-46 The amide
chemical shift of the His residue (Ha) was observed at 8.14 ppm,, the amide nearest to
the Fc (Hb) was observed at 7.29 ppm,, which are both beyond 7.00 ppm indicating the
presence of inter- or intramolecular hydrogen bonding
bonding.52 The amide conjugated to Boc
(Hc) was observed at 6.07 ppm. The α-H
α of the His was observed at 4.88 ppm. The 13CNMR spectrum exhibit
exhibited 4 resonances at 172.70, 170.65, 170.52, 156.95 ppm for the
CO2Me, two NHCO and Boc
Boc-CO, respectively (Figure 3.3.2).

Fc

*

Ha

2

Hb

5

Hc

α

Figure 3.3.1 Partial 1H-NMR spectrum of Fc[CO-His-OMe][CONH
OMe][CONHC2H4NHBoc] (64) in
CDCl3 (10 mM), showing the chemical shifts assigned to the amide
amide protons: α-protons,
imidazole protons, and ferrocene protons. *Denotes the signal of residual CHCl3.

67

Figure 3.3.2 13C-NMR proton-decoupled spectrum of Fc[CO-His-OMe][CONH
OMe][CONHC2H4NHBoc]
(64) in CDCl3 (10 mM) , showing the chemical shifts assigned to the carbonyl carbons.

3.4 Evaluation of hydrogen bonding of Fc[CO-His-OMe][CO
OMe][CONHC2H4NHBoc]
In order to investigate the hydrogen bonding behaviour of 64, a variable
temperature (VT) VT-NMR
NMR study was performed in CDCl3. A temperature range of 45° to
-5°C was used to determine the intramolecular hydrogen bonding at a concentration of
10 mM. The
he values of chemical shift variation ((△δ/△T) indicate whether an interaction
is present. If H-bonding
bonding interactions are present, an increase in temperature will
weaken these interactions;
interactions resulting in an upfield shift of the resonance assigned to the
amide protons. Temperature coefficients larger than -4
4 ppb/K indicate the involvement
of the amide protons in strong hydrogen bonding.57,58 Figure 3.4.1 shows a partial 1HNMR spectrum
ectrum of the amide region of compound 64. Amide protons Ha and Hc display a
temperature dependent chemical shift of -7.2, and -7.8 ppb/K, which indicate that Ha
and Hc are involved in strong hydrogen bonding.. Conversely, the bonds weaken upon an
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increase in temperature.
temperature The amide proton Hb shows a small △δ/△T value of 2.9
ppb/K, which indicates it is only weakly hydrogen bonded.
bonded

Ha

Hb

Hc

45°C
40°C
35°C
30°C
25°C
20°C
15°C
10°C
5°C
0°C
-5°C

Figure 3.4.1 VT NMR of Fc[CO-His-OMe][CONHC2H4NHBoc] (64) within the range of 45 to
-5 °C. Arrows
rrows indicate changes
change in chemical shifts upon cooling of amide protons denoted
a
b
c
H , H and H . Protons Ha, Hb, and Hc have slopes of -7.2,
7.2, -2.9, and -7.8 ppb/K
respectively.
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Figure 3.4.2 Temperature dependence of chemical shifts for the amide protons of
compound Fc[CO-His-OMe][CONHC2H4NHBoc] (64). Ha, Hb, and Hc denote amide
protons. These protons, Ha, Hb, and Hc have slopes of -7.2, -2.9, and -7.8 ppb/K
respectively.

The chemical shift variation from CDCl3 to DMSO-d6 provides a measure of which
NH groups are engaged in hydrogen bonding, as mentioned in chapter 1.57,58 The 1HNMR spectra of 64 suggests that Ha and Hc are involved in strong intramolecular
hydrogen bonding, with only small shifts in DMSO-d6 observed. In the case of Hb the
proton shifts were observed with a △δ of 1.07 ppm. Since the value of △δ is greater
than 1 ppm, it appears that Hb is not hydrogen bonded. (See Figure 3.4.3 and Table
3.4.1).57,58
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DMSO 6 at 10 mM
Table 3.4.1 Chemical shift of the amide protons of 64 in CDCl3 and DMSO-d
Compound

64

δ (ppm)of NH in CDCl3 (DMSO-d6)

△δ (ppm)

His-CO-NH
NH

Fc-CO-NH

Boc-NH

His-NH

Ala-NH

Boc-NH

(Ha)

(Hb)

(Hc)

(Ha)

(Hb)

(Hc)

8.14 (8.16
8.16)

7.29 (8.36)

6.07

0.02

1.07

0.09

(6.16)

*

(a)

a

Hb

Hc

H

(b)

Figure 3.4.3 Partial 1H-NMR
H
spectrum of Fc[CO-His-OMe][CONHC
C2H4NHBoc] (64) in (a)
CDCl3; (b) DMSO-d6, showing the chemical shifts of amides.
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The IR spectra were recorded using KBr pellets and elucidated the hydrogen
bonding interactions of conjugate 64 in the solid state. As previously mention in chapter
1, the amide vibrations are very sensitive to hydrogen bonding. A hydrogen bonded
amide A peak corresponding to an NH stretch is usually observed between 3300-3400
cm-1. Amide I, which is the carbonyl stretching coupled with in-plane NH bending and CN
stretching modes, are generally observed between 1610 and 1695 cm-1. Signals for NH
bending and CN stretching designated amide II are observed between 1480 and 1575
cm-1. Compound 64 shows an amide A stretch at 3330 cm-1, which indicates that it is in
the H-bonded state (see Figure 3.4.4). Multiple singles corresponding to the C=O of the
methyl ester in compound 64 were observed at 1692 and 1639 cm-1, and the amide II is
observed at 1541 cm-1.56

Figure 3.4.4 Partial IR of Fc[CO-His-OMe][CONHC2H4NHBoc] (64) (KBr disk), highlighting
selected amide and carbonyl peaks. Amide A stretch is observed at 3330 cm-1 indicating
that conjugate 64 is in a hydrogen bonded state, C=O of the metyl ester is observed at
1740cm-1, amide I is observed at 1692 and 1639 cm-1 and amide II is observed at 1541
cm-1.
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The CD spectrum of compound 64, shows a negative Cotton effect in the Fc
region with a λmax at 478 nm. The negative Cotton effect indicates that conjugate 64
adopts an M-helical conformation (See Figure 3.5.1 a).44 When comparing this system to
another similar system, Fc[CO-Phe-OMe][CO-NHC2H4NH-Fmoc] (72) (Figure 3.4.5)
reported by Metzler-Nolte, both compounds show a similar CD spectrum but opposite in
sign. The difference in CD spectra between these two compounds is likely caused by the
side chains of the amino acids used.43 In the case of compound 72, it incorporates a Phe
amino acid conjugated to it, whereas 64 incorporates His. The side chain of Phe is
similar in size to His’ imidazole ring, but lacks the Lewis basic functional group. The
negative Cotton effect seen in 64 is likely caused by the imidazole hydrogen bonding
with an adjacent amide, which results in a M-helical conformation.

Figure 3.4.5 CD spectrum of compound 72 which shows a positive Cotton effect in the Fc
region. (dashed line represents compound 72). In the structural representation of
compound 72, the dashed line represents a hydrogen bonding interaction; the molecule
adopts (a) the “Semi-Herrick” or (b) the “van Staveren” conformation. Spectra modified
and reproduced from Ref. 43, with permission from Elsevier.
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Several possible hydrogen bonding patterns are feasible for conjugate 64, as
illustrated in Scheme 3.4.1. In conformation (a), the conjugate is engaging in two
intramolecular hydrogen bonding interactions, one between the amide of histidine (Ha)
and the C=O of the adjacent strand, and one between the NH Boc (Hc) and the imidazole
(see Scheme 3.4.1 a).

Alternatively, in the other possible conformation, (b) the

conjugate is engaging in two intramolecular hydrogen bonds. One is occurring between
the amide of histidine (Ha) and the second between the NH of Boc (Hc) and the carbonyl
of the adjacent His residue (see Scheme 3.4.1 b). Because of geometric constraints and
the requirement for Ha to engage in intramolecular hydrogen bonding which was seen in
the VT NMR, conjugate 64 cannot adopt the “Semi-Herrick” conformation, instead it
likely adopts the “van Staveren” conformation.43

Scheme 3.4.1 Proposed H-bonding conformations of conjugate 64. In both
conformations the amide proton of histidine (Ha) is H-bonded to the adjacent carbonyl.
In conformation (a) the NH of Boc (Hc) is H-bonded to the nitrogen of imidazole.
Alternatively, in conformation (b) the NH of Boc (Hc) is H-bonded to the carbonyl of
histidine.

74

3.5 Metal coordination properties of Fc[CO-His-OMe][CONHC2H4NHBoc]
The metal coordination properties of 64 were investigated.

Samples were

dissolved in ACN at concentrations of 1 mM. Circular dichroism spectroscopy was used
to evaluate structural changes in Fc helicity. As previously reported by Chung et al. metal
coordination through functional groups such as the imidazole of histidine can result in a
change in the helicity of the Fc core (see Figure 1.2.4).56

The spectrum of conjugate 64 displayed a negative Cotton effect in the Fc
region with a λmax at 492 nm (see Figure 3.5.1 a).

Different metal ions were then

titrated into the sample of host compound 64 at equivalent ratios of 0.2, 0.4, 0.6, 1 and
2. A positive Cotton effect was seen upon coordination to perchlorate salts of Zn2+, Cd2+,
and Mg2+ suggesting a conformational change. The compound was likely coordinating
through the ethylene diamine fragment and the imidazole ring. Additionally it is possible
that coordination occurs through the oxygen in the peptide backbone. A proposed
coordination complex is illustrated in Scheme 3.5.1 The circular dichroism data for Cd2+
suggests two species in equilibrium in a 1:1 metal to host coordination complex. This is
observed through the presence of an isosbestic point. The electrospray ionization mass
spectrometry results show 1:1 metal ion to host compound for the Mg2+, Zn2+ and Cd2+
(See Table 3.5.1).

It should be noted that all three metals can accommodate a

tetrahedral coordination environment.
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Table 3.5.1 Data of the electrospray ionization mass spectrometry of conjugate 64 in the
presence of Zn2+, Cd2+, Mg2+ in acetonitrile.
Compound

Complex composition

Found Mass

Calculated Mass

64

[M]

567.1779

567.1736

64+Zn2+

[M+Zn-H]+

630.0980

630.0994

64+Mg2+

[M+Mg-H]+

590.2

590.2

64+Cd2+

[M+Cd-H]+

680.0735

680.0741

Figure 3.5.1 CD spectra of 1 mM compound 64 (a), samples were then titrated with
selected metals Zn2+, Mg2+ and Cd2+. All metals were used as their perchlorate salts.
Titration equivalents of host to metal ions are denoted by the coloured lines, where the
black line represents the compound 64 free of metal ions. The yellow line denotes 0.2
equivalents, red is 0.4 equivalents, green is 0.6 equivalents , blue is 1 equivalents and
purple represents 2 equivalents.
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The change in helicity observed in the CD spectrum of conjugate 64 is likely
caused by the loss of intramolecular hydrogen bonding interactions due to the ligands
accommodating the added metal ions. This change is based on the preference of the
coordination geometry of the metal ions used. In the case of Zn2+ and Cd2+ these metals
prefer tetrahedral environments. Mg2+ may adopt tetrahedral geometry or octahedral
geometry, where it possibly further coordinates to solvent molecules.

Scheme 3.5.1 Proposed metal coordination of conjugate 64. In both structures, the
imidazole and the diamine fragment coordinate to the metal ion. In structure (a) metal
coordination may take place through the carbonyl next to Fc. In structure (b) metal
coordination may take place through the amine of His.

3.6 Synthesis of Fc[CO-Ala-His(DNP)-OMe][CONHC2H4NHBoc]
The dipeptide Ala-His(DNP)-OMe was attached to 63 by standard coupling
procedures in the presence of HOBt/EDC (Scheme 3.6.1), resulting in the formation of Fc
[CO-Ala-His-OMe][CONHC2H4NHBoc] (65). The product was isolated using silica gel
chromatography using 3% MeOH in CHCl3 (Rf = 0.15) and dried using rotary evaporation.
The product was obtained as an orange solid in 14% yield.
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Scheme 3.6.1 Synthesis of conjugate 65; (i) Fc[CONHC2H4NHBoc][CO2H](63) was
activated by HBTU/HOBt in the presence of Et3N. (ii) His-OMe and Et3N, the reaction was
allowed to stir for 72 hours before workup.

3.7 Characterization of Fc[CO-Ala-His(DNP)-OMe][CONHC2H4NHBoc]
Compound 65 was characterized by 1H-NMR and correlation spectroscopy in
both CDCl3 and ACN-d3. The chemical shifts of the amide protons are summarized in
Table 3.7.1. It should be noted that ACN acts as a hydrogen bond acceptor and because
of this, chemical shifts are different when compared to CDCl3. In CDCl3 the amide proton
of His(Ha), Fc-CO-NH(Hb), Ala(Hc), and NH of Boc (Hd) were observed at 7.57, 7.52, 7.12
and 5.67 ppm respectively (see Figure 3.7.1). The protons denoted Ha, Hb and Hc are all
beyond 7.00 ppm indicating the presence of inter- or intramolecular hydrogen
bonding.53-55 The protons on the DNP exhibited 3 resonances at 8.81, 8.54, and 7.80 ppm
which showed cross correlation in the gCOSY spectroscopy (See Figure 3.7.2). The
imidazole protons were observed at 7.59 and 7.07 ppm. In gCOSY-NMR, spin-spin
coupling between the imidazole protons were observed between signals at 7.59 and
7.07 ppm. In the

13

C-NMR spectrum, the five resonances at 173.02, 171.10, 170.52,

170.09, 156.82 ppm correspond to the carbonyl carbon atoms.
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Table 3.7.1 Chemical shift of the amide protons of 65 in CDCl3 and ACN-d
ACN 3 at 4 mM
Compound

δ (ppm) of NH protons
His-NH
His
(Ha)

Fc-CO-NH (Hb)

Ala-NH
NH (Hc)

Boc-NH(Hd)

65 (CDCl3)

7.57

7.52

7.12

5.67

65 (ACN-d3)

7.71

7.10

7.17

5.97

Fc
α2

v

DNP

2
Ha

H

(a)

DNP
(b)

5
b

a

H 2

b

H

Hc

Hd

Fc
α2

d

H

w

w

α1

5
Hc

β2

β1

β1

x
y

β2
z

α1

Figure 3.7.1 1H-NMR
NMR spectra of 10 mM Fc[CO-Ala-His(DNP)-OMe][CONHC
Fc[CO
OMe][CONHC2H4NHBoc] (65)
in (a) CDCl3; (b) ACN-d
d3, showing the chemical shifts of amides, as well as select protons
indicated
icated by the structure above. v Denotes the signal of residual CHCl3, w denotes
residual MeOH, x denotes residual H2O, y denotes residual CD2HCN and z denotes residual
silicone grease.
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*

Figure 3.7.2 gCOSY spectrum of Fc[CO-Ala-His(DNP)-OMe][CONHC2H4NHBoc] (65) at 10
mM in CDCl3 showing the spin-spin coupled systems: black being DNP, red denoting His,
green denoting the ethylene fragment, and blue denoting the Ala. * Denotes residual
CHCl3.

3.8 Evaluation of H-bonding in Fc[CO-Ala-His(DNP)-OMe][CONHC2H4NHBoc]
VT-NMR was used to investigate hydrogen bonding interactions of 65, between
the temperature range of 45 and -5 °C. The sample was dissolved in ACN-d3 at a
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concentration of 8 mM. The Four amide protons showed a showed a temperature
dependant shift. Where protons Ha, Hb and Hc showed small △δ/△T shifts of -3.4, -2.6,
and -2.8 ppb/K respectively. As previously mentioned, because these values are small
this indicates that these hydrogen bonding interactions are most likely intermolecular
hydrogen bonding.37 In contrast, the diamine linker amide proton Hd showed the
strongest temperature dependence of -6.2 ppb/K. This indicates that the amide engaged
in intramolecular hydrogen bonding. (See Figure 3.8.1 and 3.8.2)

Figure 3.8.1 Plot of temperature dependant on chemical shifts for amide protons of
compound Fc[CO-Ala-His(DNP)-OMe][CONHC2H4NHBoc] (65). The NMR spectra were
recorded in the temperature range of 45 to -5 °C at a concentration of 10 mM in ACN-d3.
Amide protons Ha, Hb, Hc and Hd showed △δ/△T shifts of -3.4, -2.6, -2.8 -6.2 ppb/K
respectfully.
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Ha

Hb

Hc

Hd

45°C
40°C
35°C
30°C
25°C
20°C
15°C
10°C
5°C
0°C
-5°C

Figure 3.8.2 VT 1H-NMR spectra of Fc[CO-Ala-His(DNP)-OMe][CONHC2H4NHBoc] (65) (10
mM) in ACN-d3. The spectra were recorded in the temperature range of 45 to -5 °C.
Arrows indicate direction of change upon cooling. Amide protons Ha, Hb, Hc and Hd
showed temperature dependant shifts of -3.4, -2.6, -2.8 and -6.2 ppb/K respectively.
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To study the possibilities of inter- and intramolecular hydrogen bonding
interactions, a concentration dependent 1H-NMR study was performed on conjugate 65.
Variable concentration NMR showed no significant effects on the amide protons (see
Figure 3.8.3). This is similar to the Fc peptide conjugate (Fc[CO-Ala-NH-C2H4-])2 (73)
synthesized by Milne, which also showed no concentration dependence. Interestingly,
conjugate 73 did show temperature dependent shifts of amide protons, with values of
△δ/△T = -7.4,-6.6, and 4.0 ppb/K. These shifts indicate that the amide protons of 73
were engaged in intramolecular hydrogen bonding.55

1 mM

2 mM

5 mM

10 mM

20 mM

Figure 3.8.3 Partial 1H-NMRs of conjugate 65 at concentrations of 1, 2, 5, 10 and 20 mM
in ACN-d3. The amide protons showed no significant shifts, which indicates that there
was no intermolecular hydrogen bonding present in 65.
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(a)
Figure 3.8.4 (a) Partial 1H-NMR of compound 73 synthesized by Milne. All amide protons
showed no concentration dependence indicating a lack of intermolecular hydrogen
bonding interactions. Materials reprinted with permission from Ref. 55 by permission
from the Royal Society of Chemistry.
In the IR spectra,
spectra the typical amide I peak was observed at 1683 and 1610 cm-1.
As well, amide II was observed at 1541 and 1504 cm-1. Additionally,
Additionally amide A was shifted
to a lower wavenumber at 3300 cm-1 indicating it was in the hydrogen bonded state.

Figure 3.8.5 Partial IR spectra of Fc[CO-Ala-His(DNP)-OMe][CONHC
[CONHC2H4NHBoc] (65) (KBr
disk). Amide A was seen at 3300 cm-1, amide I was seen at 1683 and 1610 cm-1, amide II
was seen at 1541 and 1504 cm-1. There were no free amide A peaks observed, only
hydrogen bonded amide A at 3300 cm-1.
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In the presence of DMSO, conjugate 65 appeared to decompose rapidly and no
insightful data about chemical shift by variation of hydrogen bonding interactions could
be gained. Less commonly ACN-d3 can be used to determine the chemical shift by
variation instead. It should be noted that ACN is not as strong a hydrogen bond acceptor
as DMSO and therefore the values of the chemical shifts were smaller. In compound 65,
the amide chemical shift of Ala-NH (Hc) only changed slightly with a △δ of 0.05 ppm
indicating it was in a strongly hydrogen bonded state. The amide protons of His (Ha)
were shifted by 0.14 ppm, indicating it was only weakly hydrogen bonded, far less so
than Hc. Amide protons Fc-CO-NH (Hb) and Boc-NH (Hd) both showed the greatest
chemical shifts of 0.42 and 0.30 ppm respectively, indicating they are not hydrogen
bonded.76,77 A proposed hydrogen bonding arrangement is illustrated in Scheme 3.8.1.

Table 3.8.1 Chemical shifts of amide protons in conjugate 65. Samples were run in CDCl3
and ACN-d3 at 4 mM.
δ (ppm)of NH in CDCl3 (ACN-d3)
△δ (ppm)
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His-NH
(Ha)

Fc-CO-NH
(Hb)

Ala-NH
(Hc)

BocNH
(Hd)

His-NH
(Ha)

Fc-CO-NH
(Hb)

Ala-NH
(Hc)

BocNH
(Hd)

7.57
(7.71)

7.52
(7.10)

7.12
(7.12)

5.67
(5.97)

0.14

0.42

0.05

0.30

Conjugate 65 was engaged in intramolecular hydrogen bonding interactions; this
is proven by the non-linear CD signal observed. This was caused by the Fc core retaining
a locked conformation caused by hydrogen bonding interactions, as previous studies of
similar compounds have disscussed.52-55 The data collected are somewhat contradictory.
The VT experiment showed that the NH of Boc (Hd) is strongly hydrogen bonded, likely
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intramolecularly. The chemical shift by variation experiment showed that Fc-CO-NH (Hb)
is not hydrogen bonded, which agrees with other data collected. However, the chemical
shift by variation data suggested that the NH of His (Ha) and Ala (Hc) are both strongly
hydrogen bonded. This directly contradicts the VT data collected. For these reasons,
select proposed hydrogen bonding arrangements are listed in Figure 3.8.6. In possibility
(a), 65 is engaged in two intramolecular hydrogen bonding interactions, between the
NHs of Ala (Hc) to the adjacent carbonyl, and the NH of Boc (Hd) to the imidazole of His.
In possibility (b), 65 is engaged in two intramolecular hydrogen bonding interactions,
between the NHs of Ala (Hc) to the adjacent carbonyl, and the NH of Boc (Hd) to the
carbonyl of His. In possibility (c), both NH amides of Ala (Hc) and His (Ha) are engaged in
intramolecular hydrogen bonding interactions between the adjacent strand carbonyl
O

groups.

H
N

O
H
N
Fe

N
H

Fe

O

H
N
O

(a)

N
H

DNP

O
O

Fe

O
H
N
O

(c)

N
O

N
H

(b)
H
N

N

O

O

N DNP

O

O

O
H
N

N

O

N
H

O
NH
O
O

DNP

O
N

H
N

N
O
O

Scheme 3.8.1 Proposed possible hydrogen bonding arrangement for conjugate 65. In
possibility (a), 65 is engaged in two intermolecular hydrogen bonding interactions
between the NH amide of Ala to the adjacent carbonyl, and the NH amide of Boc to the
imidazole of His. In possibility (b), two intramolecular hydrogen bonding interactions are
illustrated, between the NHs of Ala to the adjacent carbonyl, and the NH of Boc to the
carbonyl of His. In possibility (c), both NH of Ala and His are engaging in hydrogen
bonding interactions between the adjacent strands carbonyls. The dashed lines
represent hydrogen bonding interactions.
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3.9 Metal coordination properties of Fc[CO-Ala-His(DNP)OMe][CONHC2H4NHBoc]
Electrospray ionization mass spectrometry was carried out to study the metal
coordination of conjugate 65, in the presence of metal ions: Zn2+, Mg2+, Cd2+, Cu2+, Fe2+,
Cu2+, Ni2+ and Co2+ used as their perchlorate salts. The electrospray studies were carried
out in the presence of two equivalents of metal ion to conjugate 65. The mass
spectrometry data suggests the formation of a complex in the ratio of 1:1 between
conjugate 65 and the metal ion. Cu2+ failed to form a complex between 65 and the metal
ion. A typical spectra is shown in Figure 3.9.1 for [M + Co]+.

Table 3.9.1 Data of the electrospray ionization mass spectrometry of conjugate 65 in the
presence of Zn2+, Mg2+, Cd2+, Cu2+, Fe2+, Cu2+, Ni2+ and Co2+ in acetonitrile.
Compound

Complex composition

Found Mass

Calculated Mass

65+Zn2+

[M + Zn]+

867.1369

867.1380

65+Cd2+

[M + Cd]+

917.1092

917.1131

65+Mg2+

[M + Mg]+

827.2096

827.2062

65+Cu2+

[M + Cu]+

-na-

867.1462

65+Fe2+

[M + Fe -H]+

859.1427

859.1439

65+Ni2+

[M + Ni]+

861.1442

861.1442

65+Co2+

[M + Co]+

862.1421

862.1420
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Figure 3.9.1 Partial ESI-TOF-MS showing the experimental and theoretical isotopic
pattern of the Co2+ complex of conjugate 65. Assigned [M + Co]+ top experimental
isotopic distribution for [M + Co]+; bottom calculated molecular isotopic distribution.

Circular dichroism was carried out in ACN to accommodate the solubilities of
both the metal salts and conjugate 65. The CD spectroscopy samples were run at a
concentration of 1 mM. In the absence of metal ions, conjugate 65 exhibited a positive
Cotton effect at λ = 478 nm in the Fc region. This indicates that the Fc adopted a Phelical conformation.

51-54

Titration of metal ions into the sample resulted in significant

changes in the CD spectra. Perchlorate metal salts were titrated at ratios of 0, 0.2, 0.4,
0.6, 1 and 2 to conjugate 65. Addition of Zn2+, Cd2+, and Mg2+ ions induced a negative
signal in the CD spectrum. This change is attributed to a change in helicity from P-helical
to M-helical.54 The change of helicity is likely caused by the coordination of the ethylene
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diamide fragment and the imidazole to the metal ions. Further coordination may have
occurred through the NH of the peptide backbone.
Isosbestic points were observed between 441 and 442 nm for Zn2+ and Mg2+.
However, Cd2+ did not have a clear isosbestic point. The presence of the isosbestic point
indicates that the complex is in equilibrium, likely forming in a 1:1 ratio with conjugate
65 to metal ion, as also supported the mass spectrometry data.75

Figure 3.9.2 CD spectra of compound 65. The sample is shown free of metal ion in (a).
Samples were titrated with selected metals, Zn2+, Mg2+, and Cd2+. All metals were used
as their perchlorate salts. Titrations are denoted by the coloured lines where the black
line represents the compound 65 free of metal ions, yellow line denotes 0.2 equivalents,
red is 0.4 equivalents, 0.6 equivalents is green, 1 equivalents is blue and 2 equivalents is
purple. In the presence of 2 equivalents of Mg2+, Zn2+ and Cd2+ all three spectra show a
strong negative Cotton effect, indicating a change in helicity from P-helical to M-helical.
Initial concentration of the sample was 1mM in ACN.
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When chiral ligands were coordinated to optically active metal ions, the CD
signals were constructive or destructive depending on whether the resulting metal
complex gave rise to a new positive or negative CD signal.79-81 It should be noted that of
the metal ions used only Ni2+, Cu2+, Co2+, and Fe2+ were optically active in the Fc region
and could contribute to the observed CD pattern. In the presence of Ni2+ and Co2+, the
CD band in the Fc region was maintained, but a blue shift was observed. This was likely
due to overlapping CD bands of both metal ions Ni2+ and Co2+ with the CD band of Fc. In
the presence of Fe2+ the CD signal was diminished, which may have been caused by a
destructive contribution of the coordinated Fe2+.
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Figure 3.9.3 CD spectra compound 65, which were titrated with selected metal ions,
Ni2+, Co2+, Fe2+ and Cu2+. All metals were used as their perchlorate salts. Titrations are
denoted by the coloured lines where the black line represents the compound 65 free of
metal ions, yellow line denotes 0.2 equivalents, red is 0.4 equivalents, 0.6 equivalents is
green, 1 equivalents is blue and 2 equivalents is purple. In the case of Ni2+ and Co2+, a
blue shift was observed by the spectra shifting to a higher wavelength.

The metal ion Ni2+ usually crystallizes in square-planar geometry over
tetrahedral when coordinating with short chain amino acids.79-82 Examples of this are
Gly-Gly-Gly-Gly and Gly-Gly-His-NHOH, which both formed square-planar complexes in
the presence of Ni2+ (see Figure 3.9.4).83,84 Due to this trend, it is highly likely that
conjugate 65 would also form a square-planar Ni2+ species in the presence of Ni2+ ions.
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(a)

(b)

Figure 3.9.4 Selected molecular structures of Ni2+ peptide complexes, which adopted
square-planar geometry of the metal ion. Species (a) Ni(Gly-Gly-Gly-Gly) anion, and
species (b) Ni(Gly-Gly-His-NHOH). Figure 3.9.4 (a) reproduced from Ref. 83 with
permission from Elsevier.Figure 3.9.4 (b) materials reprinted with permission from Ref.
84, by permission from the Royal Society of Chemistry.

Klewpatinond and Viles have made selection rules for rationalizing circular
dichroism spectra of Cu2+ and Ni2+ histidine complexes. They demonstrated that Cu2+
and Ni2+ His peptide complexes possess a positive Cotton effect at λmax ≈ 540 nm for Cu2+
and 440 nm for Ni2+.78 The sequence of amino acids preceding the His residue had a
significant influence on the spectra. A chiral amino acid like Ala coordinating through
the nitrogen atom in the backbone induced a negative band centered at 480 nm,
whereas an achiral amino acid like Gly did not add a contribution. The negative CD
signal caused by the Ala resulted in a destructive CD signal overall (See Figure 3.9.5). In
the CD spectra observed for Ni2+ of conjugate 65, there was no destructive CD band
centered at 480 nm suggesting that the Ni2+ is not coordinating through the nitrogen
atom in the peptide backbone. However, further investigation is necessary to confirm
this. In the CD spectra for Cu2+, the signal showed a decrease in intensity around 480 nm,

92

however due to the lack of the molecular ion peak in the MS studies, it did not likely
form in a 1:1 ratio.

(a)

(b)

(c)

Figure 3.9.5 (a) Schematic of the square-planar metal binding of Ni2+ and Cu2+ to the 4N
peptide sequence where R = H, CH3, and R1 = H, CH3. (b) The CD of Ni2+ complexes bound
to Ala-Ala-His (AAH), Ala-Gly-His (AGH), Gly-Ala-His (GAH), and Gly-Gly-His (GGH) at
concentrations of 0.1 mM peptide to 1 equivalent of Ni2+ ion. It was found that different
side chains in different positions contribute to predictable CD spectra of the resulting
complexes. Spectrum (c) is the Ni2+ CD of Ni1Gly-Ala-His subtracting Ni1Gly-Gly-His. This
shows the contribution of the Ala as the second amino acid in the sequence. This can
also be applied to the Cu2+ complexes as well, which is not depicted here. Materials
reproduced from Ref. 81 with permission from Elsevier.
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Scheme 3.9.1 Schematic representation of the proposed coordination of metal ion M2+
with conjugate 65. This system appears to accommodate both tetrahedral and squareplanar geometries depending on the metal ion used, although the MS failed to show the
molecular ion peak of [65 + Cu]+. This indicates it may be geometrically constrained and
prefer tetrahedral coordination modes. In proposed geometry (a), the metal ion is
coordinating through the amide bonds and the imidazole of His. The CD signal of
conjugate 65 did not show a destructive band when coordinated with Ni2+ at 480 nm.
Previous studies have shown that Ni2+ is likely not coordinated through the amide of Ala.
For this reason, possible coordination (b) has been proposed.

3.10 Synthesis of compound Fc[CONHC2H4NH-His(Boc)-Boc][CO2Me]
Compounds 64 and 65 were obtained in relatively low yields, 20% and 3%
respectively. Because of these low yields, an alternative synthesis was attempted where
the NH-Boc was deprotected and conjugated with a histidine residue which resulted in
conjugate 66 at a yield of 30%. Methyl ester deprotection was attempted to yield
compound 75. See Figure 3.10.1 for synthetic strategy. Unfortunately, even after
several attempts this resulted in a black precipitate, which was later confirmed be a
mixture of undesired products. This pathway was ultimately abandoned due to time
constraints. The desired product would have been conjugated to di- and tripeptides had
the deprotection been successful. The deprotection was attempted many different
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ways, including the use of bases LiOH and NaOH (with equivalent of base ranging from 1
to 5) in THF.

Scheme 3.10.1 Synthesis of compound 67 and attempted synthesis of compound 75,
which could have been conjugated with amino acids to create compound 76. Synthesis
(i) TFA/DCM, (ii) HOBt, HBTU, Boc-His(Boc)-OH, Et3N. (iii) LiOH in THF. (iv) HOBt, HBTU
and peptide sequence (NH2-AA1-AA2-AA3-OMe).

3.11 Attempted synthesis of dicarboxylic acid conjugates
In recent years, Fc-peptide-conjugates which are able to coordinate to metal ions
have been synthesised, for example, the previously mentioned conjugate Fc[COHis(DNP)- Gly-OMe]2 (49) was reported by Chung in 2009.56 The conjugate showed a
high affinity for binding to metal ions, so the idea to synthesize systems with more
coordinating peptides was proposed. Much effort was put into attempted coupling of
the dipeptide H-His(DNP)-His(DNP)-OMe to Fc[CO2H]2. During the attempted synthesis
of Fc[CO-His(DNP)-His(DNP)-OMe]2 (69) the reaction was monitored by TLC. At the start
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of the reaction, a single orange spot was observed corresponding to the Fc[CO2H]2.
After addition of the coupling reagent, two new red spots appeared after 30 minutes
corresponding to the Fc[CO-OBt][CO2H] and the N-oxide form of Fc[OBt][CO2H] which is
inactive. After 2 hours, the initial spot corresponding to Fc[CO2H]2 had greatly
diminished. Following this, 2.4 equivalents of H-His(DNP)-His(DNP)-OMe were added,
and again the reaction was monitored by TLC. Several new spots were observed.
However, none of them corresponded to the desired product. The synthesis was
repeated with a wide variety of coupling reagents including EDC, DCC, and BOP; none of
which yielded the desired product upon purification. A method used by Hirao and coworkers using Fc[COCl]2 (67) and directly coupling to the peptide was attempted.
Fc[COCl]2 (67) was synthesized according to a standard literature procedure.69 The
desired product was obtained in a crude mixture and desired compound’s molecular ion
peak appeared in the MS with a calculated mass for C62H50N20O24Fe[H+] = 1515.273 and
an observed m/z of 1515.266. It was speculated that steric hindrance might interfere
with molecule formation so a model system was constructed using Spartan ’08
molecular modeling software. The model systems suggests that partial encapsulation of
the carboxylate group during formation may lead to poor yields when forming conjugate
77 (Figure 3.11.2).
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Scheme 3.11.1 Attempted synthetic scheme for synthesis of Fc[CO- His(DNP)-His(DNP)OMe]2 (78). All following reactions were done in DCM initially. Traditional coupling
methods for synthesis of Fc peptide conjugates were employed using standard reagents
of (i) EDC/DCC, HOBt (ii) H-His(DNP)-His(DNP)-OMe in the presence of Et3N. (iii) BOP
reagent, (iv) 2.6 equivalents of the H-His(DNP)-His(DNP)-OMe. (v) oxalyl chloride (COCl)2
yielding Fc[COCl]2 (67). Fc[COCl]2 was isolated and then reacted, (vi) 2.05 equivalents HHis(DNP)-His(DNP)-OMe. Only in the presence of Fc[COCl]2 was the desired conjugate
78 observed by MS. The desired product was only observed using the most reactive of
the coupling methods, the acyl chlorides.

Figure 3.11.1 Spartan space filling model of Fc[CO-His(DNP)-His(DNP)-OMe]2 (78)
(Legend: oxygen is red, nitrogen is blue, hydrogen is orange, carbon is gray, and iron is
green). Partial encapsulation of the CO2H on the Fc by the His(DNP)-His(DNP)-OMe of
the adjacent strand might contribute to the poor formation ability of conjugate 78.
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Another attempted synthesis of a similar compound with smaller side chain
peptides utilizing H-Ala-His(DNP)-OMe and Fc[COCl]2 was conducted. The desired
product Fc[CO-Ala-His(DNP)-OM]2 (68) was isolated in a very limited yield (1%, 0.01g)
with impurities still present in the 1H-NMR spectrum. The molecular ion peak for the
desired product was also found and calculated for C44H42N12O16Fe to be 1051.2 and
observed a m/z of 1051.2.

Scheme 3.11.2 Synthetic scheme for synthesis of conjugate Fc[CO-Ala-His(DNP)-OMe]2
(68) using Fc[COCl]2 (67)in the presence (i) Et3N, H-Ala-His(DNP)-OMe in dry DCM.
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CHAPTER 4: Conclusions and Outlook
4.1 Conclusions

Research described in this thesis centers around the preparation of a series of
previously unknown ferrocene-peptide conjugates. New ferrocene-peptide conjugates
have been prepared by peptide coupling strategies and have been characterized by 1HNMR,

13

C-NMR and CD spectroscopies and by MS spectrometry. Several points should

be noted:
First, the conformation of the Fc-peptide conjugates 64 and 65 possess different
axial chairalties, which appears to be caused by positional variations of His. When His
was the first amino acid conjugated to the Fc-scaffold, the Fc signal in the CD showed a
negative signal, indicating an M-helical conformation. When the His residue was the
second amino acid conjugated to the Fc scaffold, conjugate 65 showed a positive CD
signal in the Fc region. This indicated the Fc is adopting a P-helical conformation. 42,47
Second, CD titrations with metal ions and conjugates 64 and 65 revealed that the
nature of the coordinating metal ion influences the helicity of the Fc conjugate. In the
case of conjugate 65, when in the presence of excess Mg2+, Zn2+ and Cd2+ the CD
spectrum shows a negative Cotton effect in the Fc region, while the observed effect is
positive in the absence of these metal ions. The CD of 64 contains a positive Cotton
effect in the Fc region in the presence of Mg2+, Zn2+ and Cd2+. From these studies it
appears that tetrahedral metals cause a switch in the Fc helicity.
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Intermolecular hydrogen bonding interactions likely induced the helical
conformations.

VT-NMR spectroscopy studies suggest strong hydrogen bonding

interactions are present in conjugate 64, where protons Ha and Hc show shifts of -7.2
and -7.8 ppb/K respectively.
The metal coordination properties of conjugates 64 and 65 were explored with
different metal ions. The MS studies show that the conjugates tend to form in a 1:1 ratio
with a few exceptions.

4.2 Outlook

While we have some indication of the structural properties of conjugates 64 and
65, X-ray diffraction studies of single crystals of these conjugates have not been
possible. Such studies would unambiguously determine the structure and indicate the
presence of hydrogen bonding arrangement of conjugates 64 and 65. In addition, X-ray
analysis of the effects of metal ion coordination need to be carried out to determine the
coordination environment in more detail. These studies would also provide useful
information about the influence of the metal ions on Fc helicity.
Added titration experiments by 1H-NMR spectroscopy using metal ions would
give information about the binding constants and binging sites of the conjugates and
these should be carried out in the near future.
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Additional metal complexation studies using electrochemical techniques are
needed before and after the addition of metal ions to determine whether these
conjugates are able to recognize metal ions and, if so, how selectively they are able to
do so.
Lastly, the concept of using these systems to model the active sites of specific
biological systems needs to be addressed. Building on the scaffold system developed by
extending the conjugation of amino acids by controlled deprotection allows for selective
control of sequence used. the model systems need to be expanded and more specific
binding environments need to be chosen and modeled. Modeling a biologically inspired
active site would provide insight into how the active sites work in nature. Active sites
such as those present in urease are of particular interest.
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CHAPTER 5: Appendix
5.1 Supplementary information

Figure S1 1H-NMR VT spectrum of conjugate 64 (10 mM, CDCl3).

108

Figure S2 13C-NMR proton decoupled spectrum of conjugate 64 (10 mM, CDCl3).

109

Figure S3 Heteronuclear single quantum coherence
c
(HSQC) spectrum of compound 64 (10 mM, CDCl3).

110

Figure S4 MS(ESI+) spectra for compound 64. The top spectrum is the experimental isotopic distribution
pattern, and the bottom spectrum is the calculated isotopic distribution pattern. The calculated m/z for
conjugate 64 is 567.17805.

+

Figure S5. MS(ESI+) spectrum of [64
[ + Mg] , showing the experimental molecular ion peaks of

the Mg2+ complex of conjugate 64, assigned [64 + Mg]+. The
he calculated molecular ion peak is 590.2
m/z and the observed molecular ion peak is 590.2 m/z. The experimental value is not accurate enough
to unambiguously determine if the complex formed or not.
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Figure S6 MS(ESI+) spectrum of [64+Zn-H]+. A measured m/z of 630.09804 was detected. Item 1 in the

table indicates the calculated m/z of the desired complex and also included additional
information such as the formula and associated error.
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Figure S7

13

C-NMR proton decoupled spectrum of conjugate 65 (20 mM, CDCl3)..
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Figure S8 HSQC spectrum of conjugate 65 (20 mM, CDCl3).
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Figure S10 1H-NMR VT spectra of conjugate 65 (8 mM, CDCl3).

115

Figure S11 MS(ESI+) spectrum of conjugate [65 + H]+. A measured m/z of 805.2211 was observed. Item

2 in the table indicates the calculated m/z of the desired complex and also includes additional
information such as the formula and associated error.

116

Figure S12 MS(ESI+) spectrum of conjugate [65 + Cd]+, showing the experimental mass to charge

ratio of the Cd2+ complex of conjugate. Item 1 in the table indicates the calculated m/z of the
desired complex and also includes additional information such as the formula and associated
error.

+

Figure S13 MS(ESI+) spectra of [65 + Co] , showing the experimental and calculated isotopic

distribution pattern of the Co2+ complex of conjugate 65. Assigned [M + Co]+ Top experimental
isotopic distribution for [M + Co]+; Bottom calculated molecular isotopic distribution.
117

Figure S14 MS(ESI+) spectra of conjugate [65 + Fe]+ showing the experimental and calculated

isotopic distribution pattern of the Fe2+ complex of conjugate 65. Assigned [M + Fe - H]+ Top
experimental isotopic distribution for [M + Fe - H]+; Bottom calculated molecular isotopic
distribution.

Figure S15 MS(ESI+) spectra of conjugate [65 + Mg]+, showing the experimental and calculated

isotopic distribution pattern of the Mg2+ complex of conjugate 65. Assigned [M + Mg]+ Top
experimental isotopic distribution for [M + Mg]+; Bottom calculated molecular isotopic
distribution.
118

Figure S16 MS(ESI+) spectrum of conjugate [65 + Ni]+, showing the experimental isotopic

distribution pattern of the Ni2+ complex of conjugate 65. Item 1 in the table indicates the
calculated m/z of the desired complex and also includes additional information such as the
formula and associated error.

Figure S17 MS(ESI+) spectra of [65 + Zn]+. The figure shows the experimental and theoretical isotopic

pattern of the Zn2+ complex of conjugate 65. Assigned [M + Zn]+ Top experimental isotopic
distribution for [M + Zn]+; Bottom calculated molecular isotopic distribution.
119

Figure S18 1H-NMR spectrum of conjugate 66 (25 mM, CDCl3).

120

Figure S19 1H-NMR spectrum of conjugate 68 (2 mM, CDCl3).
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Figure S20 MS(ESI+) spectrum of conjugate 68. The calculated m/z for conjugate 86 is 1050.2191. The
experimental value is not accurate enough to unambiguously determine if the compound formed.
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Figure S21 MS(EI) spectrum of conjugate 78. The experimental value is not accurate enough to
unambiguously determine if the compound formed.
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